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SEQUENCE SPECIFICITY OF TENIPOSIDE-INDUCED DELETION AND 
INSERTION MUTATIONS AT THE APRT LOCUS OF CHINESE HAMSTER CELLS 
ABSTRACT 
A d issertat ion submitted in part ial ful f i l lment of the 
requirements for the degree of Doctor of  Phi l osophy at the 
Medical College of Virginia , Virginia Commonwea lth University . 
Y i -Hong Han 
Medical College of  Virginia--Virginia Commonwea lth University , 
199 2. 
Advisor : Dr . Lawrence F .  Povirk 
Previous studies suggested that teniposide is a strong 
c lastogen , and that the DNA breakage effect of this drug is 
mediated by the nuc lear enzyme topoisomerase I I . Ripl ey et a l  
found evidence for a correspondence between sites of  acridine-
induced frameshift mutat ions in bacter iophage T4 and sites o f  
in vitro DNA cleavage b y  T4 topoisomerase I I . T o  ident i fy the 
sequence spec ificity of teniposide- induced de letion and 
insert ion mutations in mamma l ian c e l ls , the CHO-D4 2 2  c e l l  
l ine , which i s  hemizygous a t  the aprt locus , was empl oyed in 
this study . S ixty-eight teniposide- induced and 42 spontaneous 
aprt mutants were analyz ed at the DNA sequence leve l . Compared 
with the spectrum of spontaneous mutations in which two thirds 
of the mutations are base subst itut ions , two thirds of 
teniposide- induced mutations are deletions and insertions of 
different s i z es .  Significant site correspondence between 
teniposide- induced deletion/ insert ion mutations and in vitro 
x i  
DNA double strand cleavages b y  pur i f ied mamma l ian 
topoisomerase I I  was a lso found in this study , which suggests 
that the maj ority of teniposide- induced de letions and 
insertions observed in this study were generated at the sites 
of topoisomerase I I  mediated DNA double strand breaks in the 
cel ls . However , considering the positions of the double 
cleavage sites in the mutation sequences , no consistent 
pattern was found which could suggest a unif ied mechanism of 
DNA double strand break repair . Three models are proposed to 
try to explain the possible events occurr ing in the ce l ls 
f o l lowing teniposide exposure which resulted in observed 
deletion and insertion mutat ions . 
INTRODUCTION 
Teniposide ( 4 ' -dimethyl-epipodophyl l otoxin-thenyl idene 
beta-D-glucopyranoside ; VM-2 6 ,  Figure 1) is a semisynthetic 
epipodophy l l otoxin derivative which actively used in c l inical 
cancer chemotherapy since early 1 9 7 0 ' s .  
Previous studies showed that ten iposide produced a 
cytotoxic effect in mamma l ian cells ma inly by causing 
extensive DNA single and double strand breaks ( Loike et a l . , 
1 9 7 4 ) , and the DNA fragmentation ef fect of teniposide was 
mediated by topoisomerase I I , an essent ial nucl ear enzyme 
which functions to reso lve DNA topo logical problems dur ing 
certa in genetic activities such as repl ication and 
transcr iption ( Long and Minocha , 1 9 8 3 ) . Teniposide is able to 
inhibit the enzyme ' s  transient DNA breakage resea l ing 
activity , and this is presumably the ma in mechanism of  action 
of the drug. 
Therapy-related acute mye loid leukemias have been known 
to occur among long term cancer survivors who were treated 
with radiation and / or certa in anticancer drugs such as 
a lkylating agents . A unique type of acute monocyt ic l eukemia 
has been ident i f ied in recent years and attr ibuted to the use 
of epipodophyl l otoxins and other topo isomerase II inhibitors 
1 
OH 
Podophyllotoxin Etoposide Teniposide 
Fugure 1. Structural formulas of podophyllotoxin, etoposide and teniposide. 
tv 
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including acridines and anthracyc l ines , etc . ( Rata in et a l . ,  
1 9 8 7 ) . The demand for effective ant icancer drugs with greater 
therapeut ic indexes urges us to provide detai led knowl edge 
about the mutagenic propert ies of drugs l ike teniposide in 
order to direct future efforts in drug deve lopment . 
Teniposide was found to be strongly mutagenic in 
mamma lian cel ls as indicated by a sign i f i cant increase in the 
mutat ion frequenc ies at the hypoxanthine-guanine 
phosphoribosyl transferase (hgprt ) and the thymidine k inase 
( tk )  loci fol lowing teniposide treatment ( S ingh and Gupta 
1 9 8 3 ; DeMar ini et a l . , 19 8 7 ) . s ister chromatid exchanges were 
a lso induced by teniposide 
ce l ls . However , the drug 
in Chinese hamster ovary ( CHO ) 
fai led to exhibit sign i f icant 
mutagenic effect on a number of prokaryot ic mutagenesis 
systems ( Gupta , et aI , 1 9 8 7 ) . These results suggest that 
teniposide is a strong clastogen and that the DNA breakage 
e f f ect of the drug is probably due to the inhibit ion of 
mamma l ian topoisomerase I I . 
Due to the lack of good mode l systems , only a few studies 
were focused on looking for the DNA sequence spec i f i c ity of 
mutations induced by topoisomerase II inhibitors , and none of 
the work was done in mamma l ian cel ls . Ripley et al ( 1 9 8 8 )  
reported that hotspot sites for acridine- induced frameshift 
mutations in bacteriophage T4 correspond exactly to the in 
vitro c leavage sites of the T4 topo isomerase I I . These results 
not only suggested that inhibit ion of T4 topo isomerase I I  by 
acridine was responsible for the generat ion of the observed 
4 
mutations , but a lso showed that the in vivo topo isomerase I I  
mediated DNA cleavages could b e  reproduced in vitro with the 
same sequence speci f i c ity . It would be especi a l ly sensible to 
f ind out whether such co-speci f i c ity is a lso present in 
mamma l ian cel ls . 
The present study is a imed to reveal the DNA sequence 
speci f ic ity of  teniposide- induced mutations in mamma l ian 
c e l ls . A special CRO ce l l  l ine D4 2 2 , which is hem i zygous at 
the aprt gene , was employed in this study . The aprt gene 
encodes the nonessential enzyme aden ine phosphoribosyl 
transferase , the product of which , adenosine-5 ' -monophosphate 
(AMP) is used in DNA synthesis . Cel ls that carry mutationa l ly 
inacti vated aprt genes could be selected by 8 -az aadenine , 
which is a toxic ana log of aden ine . Because of the hem i zygous 
nature and the sma l l  s i z e  ( 2 . 6  kb ) of the locus , the aprt 
mutants could be analyz ed at the DNA sequence leve l . possible 
co-specificity between teniposide- induced mutations and the in 
vitro topoisomerase I I  cleavage sites could provide c lues for 
ident i f ication of possible mechanisms of teniposide 
mutagenesis as wel l  as the mechanisms of DNA doubl e  strand 
break repa ir . 
LITERATURE REVI EW 
HISTORY 
Podophyl l um emodi Wa l l . ,  which grows in the H imalayan 
region , and the American Podophyl lum pel tatum L. ( may app l e , 
mandrake ) are old medicinal plants . They belong to the fam i ly 
o f  the Berberidaceae and were used by the natives o f  both 
continents as cathart ics and anthe lminthics dur ing the last 
two centuries . After Kap lan discovered the therapeut ic e f f ect 
of podophy l l in , an alcoho l ic extract of the Podophyl l um 
rhi z omes , in the treatment of condylomata acuminata in the 
1 9 4 0 s  ( Kaplan , 1 9 4 2 ) , King and Sull ivan ( 1 9 4 6 ) , Sul l ivan and 
Wechs ler ( 19 4 7 )  and others descr ibed arrest in metaphase 
produced by this plant extract . In the meantime , successes 
with condyloma therapy inspired intens ive work with mal ignant 
tumors in several separate laborator ies and podophyl l in was 
shown to exhibit a s ignificant cytotoxic effect ( Cornman and 
cornman , 1 9 5 1 ) . The chemical analys is of  podophy l l in revealed 
several compounds of which Podophy l l otoxin is the main 
cytotoxic const ituent . A l l  these substances belong to the 
class of l ignans , natural products conta ining the 2 , 3 -
d ibenzylbutane skeleton . Although possess ing antitumor 
5 
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propert ies they were unacceptable for human use because 
toxicity prevented the ir administration in high enough dosage 
to g ive sign i f icant cl inical activity ( Issel l  and Crooke , 
1 9 7 9 ) . 
In the early 1 9 5 0s ,  chemists in the pharmaceutical 
research department of Sando z , Ltd . in Switzerland reasoned 
that Podophyl lum l ignans might be present in the p l ant as 
glycosides . It was hoped that , in analogy to cardiac 
g lycosides , they would exhibit pharmacological properties 
superior to those of the aglycones . After systematic chemical 
mod i f i cation of the podophy l l otoxin molecule and test ing in 
biological systems , two preparat ions , name ly SP-G ,  the 
condensation product of the Podophyl lum glucoside fraction 
with benza ldehyde , and SP-I ,  podoph i l l inic acid ethyl 
hydra z ide were demonstrated to be therapeutically useful and 
were commercia l i z ed in 1 9 6 3 . After two years of more combined 
chemical and biological search for st i l l  better ant i tumor 
agents , a compound , namely DEPBG ( D ,  4 ' -demethyl- ; E ,  epi - ; P ,  
podophyl lotoxin ; B ,  benzyl idene ; G ,  B-D-glucoside ) was found 
in SP-G which was a potent inhibitor of cell proliferation. To 
their surpr ise , DEPBG exhibited a d i f f erent mode of action 
compared with that of previous Podophyl l um compounds : instead 
o f  producing an arrest of mitosis in metaphase , it prevented 
pro l i ferat ing c e l ls from enter ing mitosis and thus induced a 
premitot ic block ( Stahel in and Cerletti , 1 9 6 4 ) . Subsequently , 
a large number of other a ldehydes were condensed to this 
g lucoside ( Kuhn et a l . , 1 9 6 9 ; Kuhn and Wartburg , 1 9 6 9 ) and the 
7 
products were analyz ed for the ir bio logical effects . Two of  
them , the condensation products with thiophene a ldehyde 
( tenipos ide , VM-2 6 ,  Vumon ) and aceta ldehyde ( etopos ide , VP- 1 6 , 
VePesid)  were selected for cl inical testing based on their 
high cytostat ic potency in mouse leukemia L12 10  and a number 
of anima l tumor mode ls ( Stahe lin 1 9 6 9 ; 1 9 7 0 ) . 
C l inical tr ials of teniposide and etopos ide started in 
1 9 6 7  and 1 9 7 1 ,  respective ly , and promis ing therapeutic 
activities in different types of cancer have been found . I n  
1 9 7 8 , tenipos ide and etoposide were l icensed out t o  the united 
states company Bristol-Myers , which carr ied on the deve lopment 
of the two epipodophyl lotoxins and introduced etopos ide to the 
u . s .  market in 19 8 3 . 
The mechanisms of action of epipodophyllotoxins was 
understood only at the cel lular leve l unt i l  Loike et a l . 
reported fragmentation of DNA in Hela c e l l s  by tenipos ide and 
etopos ide in 1 9 7 4 . Another breakthrough was made several years 
later by Long and Minocha ( 1 9 8 3 ) who correlated the DNA 
fragmentation with the inhibit ion of the nuclear enzyme 
topoisomerase II and proposed that inhibition of topo isomerase 
I I  by tenipos ide and etoposide is responsible for in vivo DNA 
breakage and cytotox ic ity . These important f indings opened a 
new chapter of epipodophy l l otoxin history . 
CURRENT ROLE IN CANCER CHEMOTHERAPY 
s ince the f irst introduct ion of teniposide in 1 9 6 7  and 
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etopos ide in 1 9 7 1 ,  these drugs have been increasingly used in 
cancer chemotherapy . Teniposide and etoposide share the same 
mode of  action --- they are phase-speci f ic cytotoxic drugs 
acting in the late S and early G2 phase and inducing a 
premitotic block in the cell  cyc l e  ( Krishan et a l . ,  1 9 7 5 ; 
Ka lwinsky et a l . ,  1 9 8 3 ) . This mode of action is quite 
d i f f erent from that of the ir parent compound podophyl l otoxin 
which is a spindle poi son caus ing inhibition of mitos i s  by 
blocking microtubular assembly (Kelleher , 1 9 7 7 ; Loike and 
Horwitz ,  1 9 7 6 a ) . Teniposide and etoposide also have very 
s imi lar experimental and c l inical features ( Roz encweig et a l . , 
1 9 7 7 ) , except that teniposide is about seven to ten t imes more 
potent than etopos ide as regards production of DNA damage and 
cytotoxicity ( Ross et a l . , 1 9 8 4 ) , and etopos ide appears to 
have a greater therapeut ic index ( Clark and S levin , 1 9 8 7 ) . 
Etoposide and teniposide had been extens ive ly stud ied in 
c l inical tr ials sponsored by the Nat ional Cancer Inst itute and 
demonstrated to be act ive ant ineoplastic agents . They not only 
have a wide range of anticancer acti vi ty , but also are 
relat ive ly we l l  tolerated ( O ' Dwyer et a l . , 1 9 8 4 ; 1 9 8 5 ) . They 
are used in treatment of several ma l ignancies either a l one or 
in combination with other cancer chemotherapeutic agents . The 
activity of etoposide aga inst different types of cancers has 
been more extensively exp lored and it is frequent ly used as a 
f irst- l ine drug in the treatment of sma l l  c e l l  lung cancer , 
germ ce l l  tumors ,  lymphomas ,  acute non- lymphocyt ic l eukemia 
and more recent ly Kaposi ' s  sarcoma associated with acqu ired 
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immune def iciency syndrome ( Arnold , 19 7 9 ; I s s e l l  and Crooke , 
1 9 7 9 ; O ' Dwyer et a l . , 1 9 8 5 ; Sinkule , 1 9 8 4 ; ) . Tenipos ide has 
tended to be used in pediatric oncology , espec i a l ly for 
neuroblastoma ( Hayes et a l . , 1 9 8 5 ; O ' Dwyer et a l . ,  1 9 8 4 ) , but 
is a l so active in acute lymphocytic leukemia , lymphomas ,  bra in 
tumors and sma l l  cell  lung cancer ( O ' Dwyer et a l . ,  1 9 8 4 ) . 
Nei ther teniposide nor etopos ide has appreciable acti vi ty 
in breast , colorecta l ,  or head and neck carcinomas and 
melanomas ( S inkule , 1 9 8 4 ; Radice et a l . , 1 9 7 9 ) . 
CHEMISTRY 
The registered name of the formulation of tenipos ide (VM-
2 6 ,  PTG , and NSC12 2 8 1 9 ) in cl inical use is Vumon ( Br i stol 
Myers ) , and its chemica l name i s  4 ' -demethyl ­
epipodophyllotoxin-9 ( 4 , 6 -0-thenyl idene-6 -D-glucopyranos id e ) . 
The empirical formula of tenipos ide is C32H32013S ,  and the 
molecular we ight is 6 5 6 . 7 .  
Tenipos ide and etopos ide were synthes i z ed starting from 
podophyllotoxin ( F ig .  1 )  which is a component of the ethano l ic 
extracts ( podophy l l i n )  of dried roots and rhi z omes of species 
o f  the genus Podophyl l um . The commonly used sources of 
podophy l l i n  are the Podophyl l um pel ta tum L. (May app le or 
American Mandrake ) and the Indian species Podophyl l um emodi 
Wa l l ich ( Ho lthuis , 1 9 8 8 ) . 
Both teniposide and etopos ide have a multiringed 
structure of the parent podophyl lotoxin l inked to a sugar 
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moiety , a glucopyranos ide ( Figure 1 ) . They d i f fer from 
podophy l l otoxin at 3 positions : they have a glucos ide moiety 
at the C-4 atom , their C-4 position is in the enanti omeri c  
configurat ion of podophyl lotoxin , and they have a hydroxy 
group at the C-4 '  position . Etopos ide and tenipos ide only 
d i f fer in sUbst itution on the glucoside mo iety of  a methyl 
group ( etopos ide ) for a thenyl idene group ( tenipos ide ) . 
Studies on the structure-activity relationship suggested 
that the hydroxy group at the C-4 ' position was essent i a l  for 
the DNA breakage activity ; ep imer i z ation of the C-4 posit ion 
of  the podophyl lotoxin rings enhanced activity , whereas 
glucosylation of the hydroxy group at the 4 -position 
diminished activity ( Loike and Horwitz ,  1 9 7 G b ;  Long et a l . , 
1 9 8 4 ) . Alteration or opening of the lactone mo iety resulted in 
a partial or comp lete inact ivat ion of etopos ide , respectively 
( Jardine et a l . , 1 9 8 2 ) ; The presence of  the glucos ide group 
greatly increased the abi l ity of etopos ide and tenipos ide to 
produce DNA breaks ( Ayres and Lim ,  1 9 8 2 ; Loike and Horwitz , 
1 9 7 Gb )  . 
Teniposide is a lmost insoluble in water , and is so luble 
i n  organic so lvents , such as a lcohols , halogenated 
hydrocarbons , tetrahydrofurane and dimethyl sul foxide 
( Holthuis , 1 9 8 8 ) . Because of the l imited solub i l ity and 
stabi l ity of etopos ide and tenipos ide in aqueous so lutions , a 
complex formulation is required for intravenous use of these 
drugs . Tenipos ide i s  suppl ied in 5 ml vials conta ining 50 mg 
o f  drug , 0 . 1 5 g of benzyl alcoho l ; 0 . 3  g of N , N-dinethyl 
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acetamidine ; 2 . 5  g of polyethoxylated castor o i l ; ma l e i c  acid 
to Ph 5 . 1 , and abso lute alcohol to 5 ml . Etopos ide i s  suppl ied 
i n  vials containing 1 0 0  mg of drug , 4 0 0  mg of Tween 8 0 ,  3 . 2 5 
g o f  polyethylene glycol 3 0 0 , 1 5 0  mg of benzyl a lcoho l , 1 0  mg 
of anhydrous citric acid and absolute a lcohol to 5 ml 
( Ro z encweig et a l . , 1 977 ) . The intact ampoules of teniposide 
and etopos ide in such formula were found to be chemica l ly 
stable for 4 years . The drugs are much less stabl e  in 
phys io logical so lut ions such as 0 . 9 % NaCl or 5 %  dextrose 
( Clark and S levin , 1 9 8 7 ) . It was also found that the stab i l ity 
of  these drugs var ies with drug concentrat ion and pH of  the 
so lut ion , but not with temperature d i f ferences or whether they 
are stored in dark or l ight environment . Lowered stab i l ity was 
observed with increased drug concentrat ion ( Clark and S levin , 
1 9 87 ) . Etoposide is most stable at pH 5 ( t1 / 2=6 0 9 h ) ; at pH 
values less than 5 the sugar mo iety is cleaved , whereas in 
bas ic so lut ions , etopos ide ep imer ises yielding the c i s- lactone 
which degrades further to give the cis-hydroxy acid der ivat ive 
( Underberg et a l . , 1 9 8 5 ) . 
PHARMACOKINETICS 
The pharmacokinet ic propert ies of tenipos ide were f irst 
studi ed by Al len and Creaven in mid 1970s us ing trit ium 
l abeled teniposide . After a s ing le infus ion , tenipos ide showed 
a triexponenti a l  decay curve (Al len and Creaven , 1 975 ; Creaven 
and A l l en , 1975 ) . When reverse-phase high performance l iquid 
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chromatography w a s  deve loped t o  improve spec i f i c ity o f  the 
analys i s , most studies showed a biexponent ial decay f o l lowing 
intravenous infusion of tenipos ide ( D ' Inca lci et a l . , 1 9 8 5 ; 
Evans et a l . , 19 8 2 ; stewart et a l . , 1 9 8 4 ) . The e l imination 
ha l f- l i f e  of tenipos ide was 6 to 1 0  hours in those studies 
showing a biexponent ial decay and between 20  and greater than 
48 hours in those exhibiting triexponenti a l  decay . The vo lume 
of distr ibution at steady state was 8 to 3 0  L/m2 . Tota l plasma 
c learance was 7 to 17 ml/min/m2 and rena l clearance was 1 to 
3 ml /min/m2 ( Clark and S levin , 1 9 8 7 ) . B i l i ary excret ion 
accounted for 0 to 10% of the dose (Al len and Creaven , 1975 ; 
Creaven and Allen , 1975 ) . Steady-state plasma concentrations 
of  tenipos ide dur ing a 72 hour infusion were l inear ly related 
to dose ( Rodman et a l . , 1 9 8 5 ) . Several studies showed that 
only 5 to 2 0 %  of the admini stered dose was el iminated as 
unchanged drug , and the maj or metabo l i c  products appeared to 
be the hydroxy acid , the picro- Iactone isomer , and the 
aglycone glucuronide ( Evans et a l . ,  1 9 8 2 ; Ho lthuis et a l . ,  
1 9 8 6 ;  Ross i  et a l . , 1 9 8 4 ) . 
The pharmacokinet ics of etopos ide was reported to f o l low 
biexponential decay after intravenous administrat ion ( C l ark 
and S levin , 1 9 8 7 ) . The terminal e l imination half- l i f e  of 
etoposide was less than that of tenipos ide , and the plasma and 
renal c learances of etopos ide were greater . 
Uptake of etopos ide and teniposide into mouse l eukemia 
L12 1 0  cells exhibited a membrane-contro l led pass ive d i f fusion , 
and 2 0 % of the drug was irrevers ibly reta ined in the c e l l  
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( A l len 1978 a ; 1978 b ;  Al len and Shirley , 1977 ) . The uptake and 
binding of teniposide was 7 to 10 t imes that of etopos ide 
( A l l en ,  1978b) , which may partly exp l a in the dif ference in 
e f f i cacy of equitoxic doses of  the two drugs (Al len , 1 9 78 a ;  
Stahe l in ,  1970 ) . Tenipos ide was more h ighly protein bound than 
etopos ide . More than 9 4 %  of etopos ide and over 9 9 %  of 
teniposide was protein-bound in vitro over a wide range of 
drug concentrations (Al len et a l . , 1 9 8 2 ) . Such magnitude of 
protein binding is l ikely to inf luence their pharmacokinetics 
in vivo ( Ba i ley-Wood et al . ,  1 9 8 5 ; G i l ette , 1973 ) . 
TOXICITY 
Short-term toxic ef fects of tenipos ide were described in 
the phase I and phase I I  cl inical tria l s . At every schedule 
tested , the most pronounced toxicity has been 
myelosuppress ion . The severity and durat ion of 
myelosuppression increases with drug dose in a gradua l 
fashion . For example , at 67 mg/m2 weekly , the maj or ity of 
patients did not manifest white blood cells counts < 2 0 0 0 /mm3 
( Muggia et a l . ,  1971 ) , whi l e  at 1 6 5  mg/m2 twice weekly in 
pat i ents wi th leukemia , ap lasia of the marrow for 
approximately two weeks was seen ( Rivera et a l . ,  1 9 8 2 ) . The 
per iod of ap lasia was pro longed by increasing the dose further 
to 2 0 0  mg/m2 ( Rivera et a l . , 1 9 8 2 ) . However , the 
myelosuppress ion induced by teniposide appeared to be no more 
severe than that induced by most other ant i l eukemic drugs 
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( R ivera et a l . , 1975 ) . 
Other toxic effects have been cons iderably less frequent . 
The incidence of type I hypersens itivity varies from 2 %  to 1 1 %  
of  patients , and n o  such reaction induced by thi s  drug has 
been reported to be fata l (We i s s , 1 9 8 2 ) . Hypersens itivity 
reactions can occur within minutes of starting the infus ion , 
with rapid onset of symptoms such as f lushing , urticari a , 
wheez ing , coughing , and vomiting ( Hayes et a l . , 1 9 8 5 ) . Acute 
rises in blood pressure and , occas iona l ly ,  hypotens ion were 
a l s o  mani fested ( Hayes et a l . , 19 8 5 ;  Muggia et a l . , 1971 ) . A l l  
these reactions , except for hypotension , were usua l ly s e l f ­
l imited and could b e  resolved with interrupt ion o f  the 
infus ion or by intravenous Benadryl and Solu-Cortef ( Hayes et 
a l . ,  1 9 8 5 ; O ' Dwyer et a l . , 1 9 8 4 ) . 
The acute reactions usua l ly occurred after repeated 
administration , but somet imes appeared on the f irst dose 
( Hayes et a l . ,  19 8 5 ) , suggest ing that thi s  drug reaction was 
probably not mediated by antibody (Weiss , 1 9 8 2 ) , although one 
pat ient was descr ibed with an IgG1 ant ibody to the drug 
( Habibi et al . , 1 9 8 2 ) . It has been suggested that the so lvent 
used for preparation of tenipos ide may be responsible for the 
a l l ergic reactions , s ince other drugs which use 
d imethylacetamide or Cremophor EL as so lvent have a l so been 
reported to induce a l lergic reactions ( Budman et a l . , 1 9 8 2 ; 
Dye and Watkins , 19 8 0 ;  Hutte l et a l . , 1 9 8 0 ) . Etopos ide dose 
not requ ire this so lvent for preparation and no acute 
anaphylactic reactions have been ascr ibed to this drug . 
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w i th r e g a r d  t o  l o n g - term comp l i c a t i on s , 
epipodophyllotoxins have been reported recent ly to be 
tumorigenic . Thi s  effect wi l l  be discussed in "therapy-related 
ma l ignancy" . 
MECHANI SMS OF ACTION 
Tenipos ide is one of the anticancer drugs which produce 
cytotoxic effects ma inly by affecting DNA topoisomerases . 
Topoisomerases are essential nuc lear enzymes that funct ion to 
resolve DNA topological problems wh ich arise dur ing some 
critical cel lular processes such as rep l i cation and 
transcription . Two maj or topoisomerases , types I and I I , have 
been ident i f ied over the past two decades in both prokaryotic 
and eukaryotic cel ls (Wang , 1 9 8 5 ; Ge l l ert , 19 8 1 ) . These 
enzymes funct ion by introducing transient protein-br idged DNA 
breaks to a l low the passage of other DNA strand ( s ) . 
Topoisomerase I breaks one strand , and topo isomerase I I  breaks 
both strands of dup lex DNA . with the strand pass ing activity , 
both enzymes can relax supercoi led DNA , and topoisomerase I I  
c a n  a lso catenate/ decatenate DNA circles . 
Eukaryotic DNA topoi somerase I I  is a 170 kd homodimer ic 
protein which i s  present in the nuclear matrix ( Earnshaw et 
a l . ,  1 9 8 5 ) . Thi s  enzyme appears to be the cel lular target of 
a number of c l inica l ly important ant icancer drugs from d iverse 
chemica l classes inc luding the interca lating agents 
( acridines , anthracyc l ines , e l l iptic ines , actinomyc ins ) and 
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epipodophyl lotoxins . These drugs interfere with the 
topo isomerase II by trapping a key cova lent intermediate of 
the breakage-re j o ining reaction , termed the " c l eavable 
complex" . Treatment of the cleavable comp lex with a strong 
protein denaturant such as SDS or a lka l i  results in DNA 
s i ngle-strand and double-strand breaks , where the 51 end of 
each broken DNA strand is  cova lently linked to a topo isomerase 
subunit via a tyrosyl phosphate bond . I n  the case of a double­
strand break , the 3 1-hydroxyl end is recessed by four bases 
( four-base staggered double-strand break ) ( Tewey et a l . , 
1 9 8 4 a ) . However , in the absence of prote in denaturants , the 
c leavable complexes can be converted to nonc leavable compl exes 
upon remova l of the drug from the reaction ( Long et a l . , 
1 9 8 6 ) . It has been widely accepted that accumulation of the 
drug-stab i l i z ed DNA-topo isomerase II cleavable comp l exes is 
l etha l to pro l i f erat ing cells and is respons ible for the 
cytotoxic activity of these drugs . 
The bio logica l funct ions of eukaryot ic DNA topo isomerase 
I I  are sti l l  not we l l  character i z ed . Studies in the SV4 0 ce l l ­
free replication system have shown that topoisomerase I I  is  
e ssential for segregat ing completely repl icated daughter 
molecules ( Yang et a l . , 1 9 87) . Its strand-passing activity is 
a l s o  important for rep l ication fork movement . The fact that 
the enzyme act ivity is dramat ica l ly increased when quiescent 
ce l l s  are st imulated for growth ( Bodley et a l . , 1 9 8 7 )  also 
indicates an important role for topo isomerase I I  in cell  
rep l ication . Unl ike DNA topo isomerase I ,  topoisomerase I I  is  
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uni formly distributed along the chromosomes ,  and i s  not 
enriched in actively transcr ibed regions ( Earnshaw et a 1 . ,  
1 9 8 5 ) . On the other hand , strong topo isomerase I I  c leavage 
s ites have been mapped to both 3 '  and 5 '  ends of the 
Drosophila heat-shock genes hsp70 ( Rowe et a l . ,  1 9 8 6 )  and the 
SV4 0 enhancer region in SV4 0- infected monkey cel l s  ( Yong et 
a l . , 19 8 5 )  which indicates that topoisomerase II may a l s o  be 
invo lved in the process of transcription . Other biological 
funct ions of eukaryotic topoisomerase II such as promotion of  
i l legitimate recombination in vitro ( Bae et al . , 1 9 8 8 ) and 
organi z ation of chromosome structure ( Earnshaw et a l . , 1 9 8 5 )  
have also been recogn i z ed .  
Like many other ant icancer drugs , tenipos ide and 
etopos ide were entered into cl inical tr i a l s  based on their 
apparent tumorostatic effects . The mechanism of act ion at the 
molecular leve l began to be uncovered a few years later when 
Loike et al . ( 1 974 ) found that treatment of c e l l s  with 
teniposide and etopos ide resulted in DNA fragmentat ion . The 
lack of an effect of these drugs on pur i f ied DNA led to the 
hypothes i s  that a nuc lear enzyme was respons ible for the drug­
induced cel lular DNA degradat ion ( Lo ike and Horwitz ,  1 9 76 ) . 
Subsequent studies showed that topo i somerase I I  was the 
putati ve cel lular target of tenipos ide and etopos ide , and 
trapping of  c leavable complexes was the pr imary mechan i sm of 
action of  these drugs ( Long and Minocha , 1 9 8 3 ; Ross et a l . , 
1 9 8 4 )  . The potency of d i fferent congeners of 
epipodophyl lotoxins in stab i l i z ing c leavable comp lexes was 
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found to corre late we l l  with the ir cytotoxic ity ( Long , 1 9 8 4 ) . 
However , the mechanism by which the drug-stab i l i z ed c leavable 
comp l exes trigger ce l l  death is st i l l  not wel l  defined . 
Severa l possibi l ities have been cons idered , which may not 
be mutual ly exclus ive . F irst of a l l ,  col l i s ion of  drug­
stab i l i z ed cleavable complexes with rep l i cation forks may be 
the initial event resulting in DNA s ingle- and double-strand 
breaks . It was found that double-strand-break-repa ir def i c i ent 
mutants were hypersens it ive to the cytotoxic effects of these 
drugs ( D ' Arpa and Liu , 19 8 9 ) . G2 arrest has been demonstrated 
to occur following drug treatment ( Drewinko and Bari og l e , 
1 9 76 ) . Ana lys is of chromosome damage in G2-arrested HeLa c e l l s  
indicated a direct correlation between the amount of  heavily 
damaged chromat in and the presence of cells  arrested in G2 
( Rao , 1 9 8 0 ) . G2 arrest apparent ly provides t ime for repa ir of 
DNA damage prior to mitos i s . However , when the level o f  DNA 
damage exceeds the repair capacity of the cel l ,  certain 
cel lular mechanisms , analogous to the SOS response in E .  col i, 
may be triggered which lead to cell death . Moreover , some c e l l  
death may b e  attr ibuted t o  the dep let ion of  functional enzyme 
due to the trapp ing of the topoi somerase II in c leavabl e  
comp l exes b y  the drug . Topo isomerase I I  appears to be 
absolutely required in some cel lular processes such as 
chromosome condensation and separat ion dur ing mitos i s  ( Uemura 
et a l . , 1 9 87 ) . Absence of topoi somerase II activity dur ing 
these critical periods of the ce l l  cyc le might lead to cell  
death . As evidence for th is hypothes i s , exposure of  a G2 
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population of CHO ce l l s  to teniposide results in the 
product ion of a sma l l  number of ce l l s  having incomp l etely 
condensed or fused mitot ic chromosomes in the form of  
micronuclei ( D ' Arpa and Liu , 1 9 8 9 ) . 
Fina l ly ,  the cel lular level of topoisomerase I I  is one of  
the important factors in determining drug cytotoxic ity . Both 
tumor cells and pro l i f erating norma l c e l l s  have higher l eve l s  
o f  topo isomerase I I . B y  us ing a number of norma l and 
neoplastic ce l l s , Hs iang et a l . ( 1 9 8 8 )  demonstrated that the 
l evel of DNA topoisomerase II was regu lated by both serum 
growth factors and the cell  dens ity in norma l ce l l s . At lower 
serum concentrat ions and higher cell  dens ities , the cel lular 
l eve l of topoisomerase I I  was reduced in these cel l s . Serum 
rep l enishment rapidly restored the high cel lular l evel of  
topo isomerase I I . However , these culture conditions had much 
less effect on topo isomerase II leve ls in tumor c e l l s . 
Furthermore ,  wh i l e  the cellular leve l of topo isomerase I I  was 
control led in norma l ce l l s  dur ing the GO/ G1 phase ,  the leve l of 
topoisomerase I I  in tumor cells  rema ined relatively constant 
throughout the ce l l  cycle . The high leve l of topo isomerase I I  
in pro l i ferating tumor cells and its a ltered regulation may 
partly explain the spec i f i c ity of topo isomerase II inhibitors 
toward neoplastic tissues . 
THERAPY-RELATED MALIGNANCY 
Therapy-related acute mye loid leukemia ( t-AML) is  a late 
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comp l ication o f  extens ive cytotoxic chemotherapy and / or 
radiotherapy for a wide range of pr imary disorders . It  
represents 1 0 %  to 1 5 %  of  a l l  AML , and is  usua l ly 
unclassif iable by the French-Amer ican-Br itish ( FAB ) system . 
The characteristics that distinguish t-AML from de novo AML 
include a high inc idence of antecedent myelodysp lastic 
syndrome with c l inical manifestations of pancytopenia , 
frequent cytogenetic abnorma l ities invo lving chromosomes 5 and 
7, and poor prognosis due to low respons iveness to 
ant i l eukemic therapy ( Fourth International Workshop , 1 9 8 4 ; 
Kantarj ian and Keating , 1 9 87) . The med ian time from initial 
treatment to bone marrow dys funct ion i s  4 -6 years . The 
deve lopment of this unique disorder has been attr ibuted to the 
use of a lkylat ing agents ( e . g .  L-phenyla lanine mustard , 
chlorambuci l  or melpha lan)  and / or radiotherapy in the 
treatment of the pr imary ma l ignanc ies ( Alba in et a l . , 1 9 9 0 ;  Le 
Beau et al . ,  19 8 6 ; Lerner , 1978 ) . 
In recent years , several cases of t-AML have been 
reported in which ne ither the morphology nor the karyotype was 
typical for the commonly seen t-AML ( Rata in et a l . , 1 9 8 7 ; Pui 
et a l . ,  19 8 9 ) . Patients with th is new type of t-AML had 
s evera l character istics in common : epipodophyl lotoxins , 
anthracycl ines or actinomyc in D were inc luded in the 
chemotherapy in combination with either c i s -platin or 
cyc lophosphamide ; this type of t-AML can be classif ied by FAB 
as types M4 ( acute mye lomonocyt ic leukemia ) or M5 ( acute 
monocyt ic leukemia)  and have cytogenetic changes invo lving 
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chromosome 1 1q [ t ( 9 ; 1 1 )  ( p2 2 ; q2 3 )  i s  frequently seen] ; there 
was no preleukemic phase , and the interval between the 
treatment of the primary ma l ignancy and the deve lopment of  t­
AML was short ( about 2 - 3  years ) ; patients with thi s  type of t­
AML responded wel l  to ant i l eukemic therapy (DeVore et a l . ,  
1 9 8 9 ) . 
The mechanisms and mo lecular events under lying therapy­
related leukemogenesis have not been studied in great depth . 
The drugs ident i f ied to cause th is new type of t-AML are 
cytotoxic agents acting ma inly through inhibition of 
topoisomerase II ( Long and stringfellow ,  1 9 8 8 ) . S ince these 
drugs are known potent clastogens and mutagens ( S ingh and 
Gupta , 1 9 8 3 ; DeMarini et a l . , 1 9 8 7 ) , it i s  reasonable to 
speculate that the clastogenic effect of  topo isomerase I I  
i nhibi tors may confer a leukemia by inducing chromosomal 
aberrations , part icularly at 1 1q2 3 . 
A recent in vitro cytogenetic study on the clastogenic 
effect of etopos ide suggested that chromosome aberrat ions 
induced by etopos ide are not random : chromosomes 1 ,  11 and 17 
were most frequent ly invo lved , wh i l e  chromosomes 4 ,  5 and X 
were seldom affected ( Maraschin et a l . , 1 9 9 0 ) . It was a lso 
noticed that R-band-rich chromosomes were s igni f i cantly more 
a ffected than G-band-rich chromosomes . Thi s  non-random 
d i stribut ion may be related to the fact that R bands are rich 
in genes that are actively transcr ibed and hence are more 
suscept ible to topoisomerase II mediated damages . It was 
suggested that , s ince most aberrat ions detected were e ither 
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trans locations or dicentrics , i l legitimate recombinations 
between non-homologous chromosomes due to incorrect repa ir 
might be the molecular event resulting in leukemogenes i s  
( Maraschin e t  a l . , 1 9 9 0 ) . 
To further def ine the genet ic loci and the critical 
regions on the chromosomes that are preferentia l ly invo lved in 
l eukemogenesis wi l l  be helpful in understanding the role 
certa in genes may play in the processes of  trans format ion . 
Deta i led informat ion on topo isomerase I I  inhibitor-induced DNA 
damage and repa ir mechanisms wi l l  also be important for 
e lucidat ing the mutagenic propert ies of these drugs at the 
molecular level . Such knowledge wi l l  be of  great value in the 
e ffort to separate the cytotox ic and mutagenic propert ies of 
these drugs in order to achieve safer chemotherapy in the 
future . 
MUTAGENESI S  
Teniposide is one of the many cytotoxic ant icancer drugs 
deve loped in recent years that produce their effects by 
interacting with cel lular DNA and caus ing a var iety of  genetic 
a lterations . Many of these drugs have been shown to be 
mutagenic and carc inogenic in a number of d i f f erent 
exper imental systems ( S ingh and Gupta , 1 9 8 3 ) . There have been 
more and more reports claiming the emergence of secondary 
ma l i gnancies among long-term cancer survivors who had been 
treated with these drugs ( Kantarj ian and Keating , 1 9 87 ;  Albain 
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e t  a l . , 1 9 9 0 ) , which rai sed the susp icion that some o f  these 
drugs may be carcinogenic . I n  view of  their widespread 
c l inical use , the mutagenic potent ial of  these drugs has come 
to be of great concern and has produced cons iderabl e  research 
interest . 
To character i z e  the ir mutagenic properties , S i ngh and 
Gupta ( 1 9 8 3 ) examined the mutagenic effects of thirteen 
ant icancer drugs ( namely , busul fan , chlorambuc i l ,  adr iamycin , 
bleomycin , daunomyc in , e l l ipticine , tenipos ide , etopos ide , 
c i s -platin , 
mitomycin C )  
dacarba z ine , lomustine , actinomycin D ,  and 
at f ive independent genet ic loci in Chinese 
hamster ovary ( CHO ) cells . The genet ic loci are those 
conferring res istance to the nuc leos ide ana logues 6-
thioguanine ( Thg') and 5 , 6 -dichlororibofuranosylbenz imida z o l e  
( DrbR ) , the cardiac glycos ide ouaba in ( OuaR ) , the protein 
synthesis inhibitor emet ine ( Emt' ) and the po lyamine synthes i s  
inhibitor methylglyoxa l-bis ( guanylhydra zone)  (Mbg' ) . Among 
these genetic loci , only the hypoxanthine-guanine 
phosphor ibosyltransferase (hgprt ) locus may be used to detect 
a wide range of genet ic lesions , inc luding those which may 
cause inactivat ion of the gene , s ince the product of th i s  gene 
is a purine salvage pathway enzyme and its function is not 
essential  for cell  growth under norma l conditions . I n  contrast 
to the hgprt locus , the other genet ic loci appear to be 
essent i a l  for cel l  surviva l and growth ( e . g . , Na + -K+ -ATPase in 
OuaR or 4 0 S  r ibosomes in Emt' mutants ) .  These loci , therefore , 
are expected to respond only to those agents which cause minor 
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DNA damages ( e . g .  base substitutions ) that lead to res i stance 
without inactivating the functions of these genes . The 
genotoxic activity of various ant icancer drugs was also 
investigated in an independent assay system based on induction 
of  s i ster chromatid exchange ( SC E )  ( Gupta and S ingh , 1 9 8 3 ) . 
Results of these studies are summari z ed in Tabl e  1 .  A l l  
thirteen ant icancer drugs showed pos itive mutagenic responses 
in both assay systems . In compar ison , tenipos ide was 
relati vely strongly mutagenic at the hgprt locus , which 
suggested that this drug is producing predominant ly the types 
of  genetic les ions ( e . g .  deletions and frameshifts ) that may 
cause inact ivat ion of the af fected funct ion . consistent with 
thi s  result is the fact that tenipos ide was also a very potent 
inducer of SCE , which makes tenipos ide a possible potent 
clastogen . 
The hgprt locus is X-l inked -- most cell  l ines have only 
one funct iona l hgprt gene . The funct ional hemizygosity of  this 
locus makes it read i ly avai lable for mutagenes is . Like the 
hgprt locus , the thymidine kinase ( tk )  locus is also one of 
the most frequently used target genes in mamma l ian c e l l  
mutagenesis assays . The t k  locus is  autosoma l ,  and norma l ce l l  
l ines have two funct ional tk genes . However , s everal 
investigators have isolated tk heterozygous l ines in rodent 
and human cel ls . The L5 178Y / TK+I-- 3 .  7 . 2C mouse lymphoma assay 
measures mutations at the funct iona l ly heterozygous tk locus 
based on resistance to tr if luorothymidine . Studies indicate 
that this assay may detect both intragen ic mutations a s  we l l  
Tab l e  1 .  Summary of the Mutagenic Effects of Various 
Anticancer Drugs in Mutagenes i s  and SCE Assays 
Relat ive Mutagenic Responses of 
Different Genet ic Markers' 
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Anticancer 
Drugs Emt' Mbg' Thg' 
SCEb 
assay 
Chlorambuci l  + ++ + +++ +++ 
Busul fan + + ++ ++ 
Lomustine + + + 
Dacarba z ine + + 
Adriamycin ++ + + 
Daunomycin ++ + + + 
B leomyc in + + + + 
E l l iptic ine ++ +++ ++ 
Tenipos ide ++ + ++++ ++++ 
etopos ide + + +++ ++++ 
c i s -Platin +++ ++++ 
Act inomycin D ++ + + 
Mitomycin C ++ ++ ++ +++ ++++ 
• Based on the mutagenes i s  s ign i f icance ration of the observed 
mutagenic responses , the mutagen ic effects of the chemica l s  
a r e  arbitrary classif ied from - ( negat ive ) t o  ++++ ( very 
strong ) . 
b Based on the fold increase in SCE as compared to the 
untreated cel l s , the potenc ies of the chemica l s  of SCE 
induct ion are arbitrar i ly class i f i ed from + ( weak ) to ++++ 
( very strong ) . 
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a s  chromosoma l mutat ions ( intergenic events resulting from 
chromosoma l rearrangements and / or funct iona l multi locus 
deletions ) affecting express ion of the tk locus . These two 
c lasses of genet ic damage were found to produce colonies with 
d i f f erent s i z e s  that can be distinguished by an automatic 
colony counter (Moore et a l . , 1 9 8 5b ) . Sma l l-colony TK mutants 
appear to result from large scale a lterat ions to chromosome 
1 1 , which carr ies the tk locus , whi l e  large-colony mutants 
appear to represent single-gene mutations ( Hoz ier et a l . ,  
1 9 8 5 )  . 
The mutagenic and clastogen ic activities of teniposide 
were evaluated in L5 178Y / TK+I-- 3 .  7 . 2C  mouse lymphoma ce l l s . At 
a dose which resulted in approximately 2 0 %  surviva l , 
tenipos ide induced as many as about 2 , 0 0 0  tk mutants / 1 06 
survivors , and the maj or ity of the mutants formed sma l l  
colonies ( DeMar ini e t  a l . ,  1 9 87) . Compared with the above 
f igure , tenipos ide induced much fewer mutants at the hgprt 
locus in CHO cells  ( S ingh and Gupta , 1 9 8 3 ) . A reasonable 
explanation is  avai lable based on previous observat ions that 
both the tk and hgprt loci were equa l ly mutable by gene 
mutagens and weak clastogens such as EMS and ICR170 , Whereas , 
agents act ing pr imar ily by clastogen ic mechanisms , such as y­
rays , and m-AMSA were extremely potent mutagens at the tk 
locus of L5 178Y cells  but were much less mutagenic at the 
hgprt locus of CHO or V79 ce l l s  ( DeMarini et a l . ,  1 9 8 7 ) . The 
heterozygos ity of the tk locus as opposed to the hem i zygous 
nature of the hgprt locus appeared to be the maj or reason for 
27 
the d i f f erences in the mutagenic response of the two loci . 
Mul t i l ocus events induced by potent clastogens might be 
recoverable at a functiona l ly heterozygous locus such as tk, 
where the loss of essential f lanking gene function might be 
compensated for by funct ional genes on the homo logous 
chromosome , whi l e  at a funct iona l ly hemizygous locus l ike 
hgprt, there is  no homo logous genetic mater ial to compensate 
for the loss of essential  f lanking gene functions , so that 
these mutants could not be recovered . In cytogenet ic analys is , 
tenipos ide was demonstrated to be a strong inducer of 
chromosome aberrat ions . It induced 244 aberrations / 1 0 0  c e l l s  
at 5 �g/ml ( DeMar ini e t  a l . , 1 9 8 7 ) . These results l ed to the 
conc lusion that teniposide is probably a potent clastogen in 
mamma l ian mutagenic test systems . 
The cytotoxic and mutagenic effects of tenipos ide and its 
congener etopos ide in bacter ial test systems has also been 
eva luated . In contrast to mamma lian cel l s , treatment of  either 
s .  typhimurium or E .  coli with a wide range concentrat ions of 
these drugs produced no appreciable increase in the mutation 
frequenc ies in several systems measuring either reverse or 
f orward mutations ( Gupta et a l . , 1 9 8 7 ) . Among these systems , 
two prokaryot ic forward mutat ion assays in which the exc is ion 
repa ir proficient E. coli K12 3 4 3 / 1 1 3  stra in was used , should , 
in princip l e , detect a l l  types of genet ic les ions that cause 
inacti vat ion of gal R or trpR gene products . However , treatment 
with up to 5 0 0  �g/ml of etopos ide caused no increase in 
mutation frequency in these forward mutation detection systems 
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[ i . e .  abil ity t o  grow i n  presence of ga lactose ( ga l + )  or 
resistance to 5-methyltryptophan ) .  These results , in addition 
to the fact that neither etopos ide nor teniposide showed 
s igni f icant cel lular toxicity in the prokaryotic systems 
suggested that epipodophyl lotoxins do not produce genotoxic 
les ions in bacter ial cells  ( Gupta et a l . , 1 9 87) . 
It has been widely accepted that the cytotoxic effects of  
teniposide and etopos ide are brought about by interaction with 
mamma lian DNA topoisomerase I I , wh ich breaks and rej oins 
double-stranded DNA in concert . The lack of toxic ity of these 
drugs in prokaryot ic as opposed to mamma l ian systems suggested 
that the enzymes from prokaryot ic and mamma l ian ce l l s  might 
d i f fer in the ir interaction with these drugs . The pur i f ied 
enzyme from mamma l ian sources is  a homodimer of a polypeptide 
cha in with molecular we ight of 170 kd ( Ge l lert , 1 9 8 1 ;  Wang , 
1 9 8 5 ) . The corresponding type I I  topoisomerase in bacter i a l  
systems is DNA gyrase wh ich is composed of two subunits with 
molecular weight of 9 0  kd and 1 0 0  kd , both of which are 
required for activity . The bacter ial enzyme a l so dif fers from 
the mamma l ian enzyme in that whi l e  the catalytic activity of 
mamma l i an topo isomerase I I  is dependent upon ATP , the 
bacterial DNA gyrase can cause re laxation of superhelical  DNA 
in the absence of ATP ( Ge l lert , 1 9 8 1 ;  Wang , 1 9 8 5 ) . On the 
other hand , the behavior of the bacter iophage T4 topoisomerase 
I I , a multisubunit protein , is  more s imilar to mammal ian type 
I I  topoisomerase and much less s imi lar to E .  coli DNA gyrase 
( Vosberg , 19 8 5 ) . Drugs that promote mamma lian topoisomerase 
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I I -mediated DNA c leavage also promote T 4  topo isomerase 1 1 -
mediated DNA cleavage ( Ripley e t  a l . , 1 9 8 8 ) . Therefore , the 
d i f f erences between topo isomerase II from d i f ferent biological 
systems in the ir interaction with teniposide and etopos ide may 
account for the observed results in these systems . 
A series of other drugs are a l so known to produce 
cytotoxic effects by disturbing DNA topoisomerase I I . These 
drugs belong to different chemical classes , e . g . , acridines , 
anthracycl ines and e l l iptic ines , represented by m-AMSA , 5 -
iminodaunorubicine , and 2 -Me-9 -0H-E+ , respectively . Unl ike 
epipodophyl lotoxins , these drugs interact directly with DNA 
molecules by interca lation . What they have in common with 
epipodophyl lotoxins is that they are a l l  able to stabi l i z e  the 
DNA-topoisomerase II complex . Good correlations have been 
f ound between the abi l ity of a drug to cause cleavable comp lex 
accumulation and product ion of cytotoxic ity ( Long et a l . , 
1 9 8 6 ) . For example , intercalators such as o-AMSA and 
e l l ipt icine which are less cytotox ic than their congeners m­
AMSA and 2 -Me-9 -0H-E+ are also much less efficient in 
stimulating cleavable comp lex format ion and producing DNA 
strand breaks in vitro (Nelson et a l . , 1 9 8 4 ; Tewey et a l . , 
1 9 8 4 ) . Whether the intercalati ve acti vi ty plays a role in 
their cytotoxic effect is sti l l  in di spute . DNA c leavage 
act ivity of  interca lators and epipodophyl lotoxins were 
observed both in cultured mamma l ian ce l l s  and in vitro system 
with pur i f ied mamma l ian or T4 topo isomerase I I , which provided 
evidence for the invo lvement of topo isomerase II in the 
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cytotoxic effects o f  these drugs . On the other hand , DNA 
s equencing analys is revealed that topo isomerase II c leavage 
s ites produced by drugs from different chemical classes are 
d i st inctly dif ferent (Tewey et a l . , 1 9 8 4 b )  which suggested 
that although topoisomerase I I  may by the common target , the 
enzyme may interact d i f ferently with d i f ferent drugs . 
The search for the sequence speci f icities of DNA 
topo isomerase II cleavage s ites both in the absence and 
presence of the drugs has been mostly l imited to in vitro 
studies ( Spitzner and Mul ler , 19 8 8 ; Capranico et a l . ,  1 9 9 0 )  
and the va l idity of the consensus sequences i n  predicting the 
c leavage s ites in l iving cel ls has been questionable . Rather 
sUbstant ial differences have been found between the 
topo isomerase II cleavage s ites in vivo and in naked DNA 
( Udvardy and Schedl , 1 9 9 1 ) . In  one of the attempts to 
character i z e  the formation of mutations induced by 
topo isomerase II inhibitors , m-AMSA was used to induce 
mutations in bacter iophage T4 and to promote T4 topo isomerase­
mediated DNA cleavage in vitro ( Ripley et a l . ,  1 9 8 8 ) . A co­
speci f i c ity of the s ites of the DNA damages in the two systems 
was found . The spec i f i c  phosphodiester bonds cleaved in vitro 
are prec isely those at which frameshifts are most strongly 
promoted by m-AMSA in vi vo . Thi s  co-spec i f i c ity enabled the 
author to postu late the mo lecular events ( incorrect repa i r )  
leading from i n i t i a l  topoi somerase I I -med iated DNA damage ( a  
doubl e  strand break ) t o  the resulting frameshift mutations 
( Rip ley et a l . , 1 9 8 8 ) . Thi s  interest ing result led us to the 
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present studies designed to determine whether such co­
spec i f ic ity is  also present in mamma l ian systems . 
CHO/ aprt SYSTEM 
Genet ic loci which encode nucleotide sa lvage pathway 
enzymes such as thymidine kinase ( tk )  and hypoxanthine guanine 
phosphoribosyltransferase (hgprt ) are most extens ive ly used as 
genet ic targets in mutagenesis studies . These enzymes funct ion 
to integrate free pur ine and pyr imidine bases into cel lular 
metabo l i sm and their activit ies are not essential for c e l l  
surviva l in norma l growth medium . The nonessential nature of 
these enzymes made it poss ible to detect a wide range of 
genetic a lterations by a single step forward selection for the 
mutants of these genes . The aprt gene , another such locus , 
encodes the sa lvage enzyme adenine phospho-r ibosyl trans f erase 
( APRT ) wh ich catalyzes the synthes is of adenos ine- 5 ' ­
monophosphate ( AMP ) from adenine and 5 -phosphor ibosy l - 1 -
pyrophosphate ( PRPP ) . The aprt locus in Chinese hamster ovary 
( CHO ) cel l s  has been used most ly in studying sequence 
spec i f i c ity of mutagenes i s  ma inly because of the ava i l ab i l ity 
of hemizygous strains , and the sma l l  s i z e  ( 2 . 6  kb ) of the 
structura l gene which makes sequencing ana lys is much easier . 
The CHO-D4 2 2  stra in was isolated by Bradley and Letovanec 
( 1 9 8 2 ) through a direct selection method by plating wild type 
CHO c e l l s  in increas ing concentrat ions of the pur ine analogue 
d iaminopur ine ( DAP ) . Loss of APRT activity occurred in two 
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s equential  steps . About half o f  tota l APRT activity was lost 
in the f irst step , and most or all of the rema ining activity 
was lost in the second step . The 04 2 2  c e l l  l ine retained 5 0  % 
of wild type CHO APRT activity was origina l ly believed to be 
a heterozygote for aprt ( Bradley and Letovanec ,  1 9 8 2 ) . 
subsequent studies , us ing Southern blot analys is , revealed 
that the CHO-04 2 2  c e l l  l ine carried a deletion of one o f  the 
aprt a l leles , which rendered this c e l l  l ine hemizygous at this 
locus ( Nalbantoglu , 1 9 8 3 ) . This partial APRT defic ient mutant 
c e l l  l ine exhibited a stable phenotype and the rate of 
spontaneous mutation from partial to tota l APRT def iciency was 
on the order of 1 0-6 per c e l l  per generat ion ( Bradl ey and 
Letovanec , 1 9 8 2 ) . The mutation frequency could be enhanced by 
treatment with a mutagen and the aprt- mutants could be 
isolated by a s imple one step selection for res istance to the 
drugs diaminopur ine or 8 -az aadenine ( Jones and Sargent , 1 9 74 ) . 
I n  contrast , a number of heterozygous aprt l ines obtained by 
s ib-selection had spontaneous mutation frequenc ies two to 
three orders higher than that of the 04 2 2  strain . In addition , 
these sib-selected c e l l  l ines were not respons ive to the 
mutagen EMS ( Bradley and Letovanec ,  1 9 8 2 ) . However , because of 
the hemizygous nature , a potential l imitation of the CHO-
04 2 2 / aprt system has been suggested to be the possible 
exclusion of  mutationa l events that would inact ivate essential 
genes within the region of hemi zygos ity ( de Jong et a l . , 
1 9 8 8 ) . 
The hamster gene coding for APRT has been isolated by 
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us ing gene trans fer and mo lecular cloning o f  trans forming DNA 
( Lowy et a l . , 1 9 8 0 ) . The aprt gene is about 2 . G  kb and i s  
composed of 5 exons and 4 introns ( Figure 2 ) . The sequence of  
the entire gene has been determined by at least two 
independent laboratories ( Na lbantoglu et a l . , 1 9 8 G a ; de Boer 
et a l . , 1 9 8 9 ) ; the earl i er sequence appears to contain several 
errors . 
The spectrum of spontaneous mutations at the aprt locus 
has been documented . Although somewhat discrepant results are 
present , the most prominent characteristics in common have 
been the predominance of G : C  to A : T  transit ions among base 
subst itutions , which account for the maj ority of  tota l 
mutat ions , the presence of short direct repeats at the termini 
o f  sma l l  deletions and the nonrandom distr ibut ion of the 
delet ion mutat ions ( Phear et a l . , 1 9 8 9 ; Nalbantoglu et a l . ,  
1 9 8 G b ;  de Jong et a l . , 1 9 8 8 ) . The latter characteristic has 
been attr ibuted to the presence of certa in DNA sequences such 
as dyad symmetry and short direct repeats in this region of 
the gene . 
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MATERIALS AND METHODS 
TENIPOSIDE MUTAGENESIS 
Cell Culture : 
The Chinese hamster ovary ( CHO ) c e l l  subl ine D4 2 2  was a 
generous gift from Dr . B .  W .  G l i ckman . This cell  l ine is  
hem i zygous at the aprt gene and reta ins 5 0  % of wild type APRT 
enzyme activity . It was origina l ly iso lated by Bradley and 
Letovanec ( 1 9 8 2 ) . The aprt gene encodes the enzyme adenine 
phosphor ibosyl transferase which cata lyz es the synthes i s  of 
adenos ine-5 ' -monophosphate (AMP ) from adenine and 5 -
phosphoribosyl - 1-pyrophosphate ( PRPP ) . The cel l s  were 
routinely ma intained in a-Minimum Essential  Medium ( Gibco ) 
supplemented with 5 % feta l bovine serum and 2 . 5  % horse s erum 
( G ibco ) . Five mi l i l iters of penic i l l in-streptomycin ( G ibco ) 
was added to each 5 0 0  ml medium to prevent contamination . A 
water-j acketed tissue culture incubator ( Forma Scient i f i c )  
kept the ce l l s  a t  3 7 ° C ,  5 % CO, . The c e l l s  were rout inely 
subcultured upon conf luence . Fol lowing a br ief wash with 
ster i l i z ed s a l ine G ( 0 . 1  roM CaCI2 · 2H20 ,  5 . 4  roM KCI , 1 roM KH2P04 , 
0 . 6 3 roM MgS04 • 7H20 ,  1 3 7  roM NaC I , 1 roM Na2HP04 • 7HP , 1 1  % D­
g lucose ) , the cells  were incubated with 3 ml of 0 . 2 5 % trypsin 
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( Gibco ) i n  a 75 mm2 tissue culture f lask ( Costar ) for about 1 5  
minutes to detach the cel l s  from the wa l l  o f  the flask . About 
2 x 1 05 cells were transferred into a new f lask containing 2 0  
m l  o f  fresh medium . 
Freez e  storage of cel l l ines was done by spinning down a 
large number of cel l s  at 5 0 0  rpm for 10 minutes and 
resuspending them in a sma l l  volume of  fresh medium to make a 
f inal concentrat ion of 3 - 5 mi l l ion c e l l s /mI . 0 . 9  ml of the 
c e l l  suspension was combined with 0 . 1  ml ster i l i z ed dimethyl 
sul foxide in a 1 . 5  ml ster i l i z ed vial and fro z en down at -70 
°C for a period of time before the cells  were transferred into 
a l iquid nitrogen tank . 
Mutagenesis assay 
Teniposide was a generous g i ft of Bristol Myers Inc . 
Ten ipos ide powder was kept at - 2 0 ° C  and was dissolved in 
d imethyl sul foxide to 1 roM stock so lution . Al iquots of  the 
stock solut ion were kept at -70 ° C  for up to two weeks . 
Each mutagenesis exper iment started from f ive 1 , 0 0 0  c e l l  
inocula t o  minim i z e  preexist ing aprt- c e l l s  in the cultures . 
After 5 6 days of mult ipl ication , 5 x 1 05 ce l l s  were 
transferred from each inoculum to a 75 mm2 f lask conta ining 2 0  
m l  o f  fresh medium and a l l owed to sett le and enter exponent ial 
growth for one day . Four of the f ive cultures were then 
mutageni z ed with d i fferent doses of teniposide ( 0 . 0 2 - 0 . 1 6 
�g/ml ) for 1 6  hours . The control culture was treated with the 
same vo lume of dimethyl sul foxide . 
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Severa l experiments were done with calcium-depl eted 
c e l l s . Prior to the drug treatment , the ce l l s  were incubated 
in  5 roM EGTA for 4 hours to depl ete calcium from the cultures . 
Var ious amounts of tenipos ide were added to the cultures and 
the drug treatment lasted only for one hour . 
At the end of drug treatment , the medium was aspirated 
and replaced by fresh medium . The c e l l s  were allowed to grow 
for one day before they were tryps ini z ed . 
To determine cell surviva l ,  2 x 700 cells  were taken from 
each culture and plated in two 5 0  mm2 tissue culture d i shes 
( Costar ) conta ining 1 5  ml med ium . After 7 days of incubat ion , 
colonies were formed from viable cells . These colonies were 
f ixed in 4 % forma ldehyde ( F isher Scient i f i c )  for 5 minutes 
and stained by 1 % crysta l violet ( S igma ) . The number of 
colonies with 100 or more ce l l s  was counted . Cel l  surviva l for 
each culture was calculated by dividing the average number of 
colonies from each treated culture by the average number of 
colonies from the contro l  culture . 
From each tryps ini z ed culture , 2 x 106 c e l l s  were 
transferred to a new f l ask with fresh medium . At the h ighest 
drug doses , there were often less than 2 x 1 06 ce l l s  rema ining 
attached to the f lask following treatment , in which case a l l  
attached c e l l s  were transferred . The cells  were a l lowed to 
grow for 6 days in order to express the aprt- phenotype . Dur ing 
the s i x  day expression period , the c e l l s  were subcultured once 
at 2 x 1 06 c e l l s  per f l ask . 
To determine mutation frequency , a tota l of three m i l l ion 
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ce l l s  from each culture were plated i n  six 5 6  cm2 d i shes in 
s e l ective medium containing 0 . 4  mM 8 -a z aadenine ( S igma ) and 
suppl emented with 5 % dialyzed feta l bovine serum and 2 . 5  % 
d i a ly z ed horse serum ( G ibco ) . During the following 7 days of  
incubat ion , the mutated cells  which were aprt def icient could 
survive in the selective medium and form colonies . In  the 
meantime , 2 x 700 cells  were also taken from each culture at 
the end of express ion period and p l ated in nonselective medium 
with dialyzed sera . Colonies formed from these cells  were 
d ivided by the number of cel l s  plated (which was 700 cel l s )  to 
g ive the plat ing efficiency of each culture . The tota l number 
of colonies formed in selective medium out of three mi l l ion 
c e l l s , corrected by plating efficiency , were used to determine 
mutation frequenc ies : 
Number of mutant colonies 
3 X 106 x Plating effic iency 
From each drug treated culture in which the mutation 
frequency at least 8 fold greater than the background mutation 
frequency from the same exper iment , two colonies were 
isolated . Colonies were also iso lated from the control 
cultures . These c e l l  l ines were grown out in selective medium 
to a large number for DNA extract ion . 
AMPLIF I CATION OF THE APRT GENE 
Extract i on of  Genomic DNA 
From each mutant strain , about 1 08 cells  were grown , 
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tryp s i n i z ed and washed twice with cold phosphate buf f ered 
s a l ine ( 1 3 7  mM NaC I , 2 . 7  mM KCI , 8 mM Na2HP04 · 7H20 ,  1 . 4  mM 
KH2P04 ) . The cel l s  were then lysed in 1 ml d igestion buf fer [ 1 0 
mM Tris-HCI , pH 7 . 5 ,  1 0 0  mM EDTA , 0 . 5  % sodium dodecyl sul fate 
( SDS ) , 25 �g/ml proteinase K ( S igma ) ] at 3 7 D C  overnight . 5 M 
NaCI was added into the lysate to make a f inal concentration 
of  0 . 1  M. An equal volume of pheno l / chloroform ( 1 / 1 )  was mixed 
with the lysate and the mixture was centri fuged at 1 , 5 0 0  rpm 
for 10 minutes . The aqueous layer was transferred into a new 
tube and subj ected to another phenol / chloroform extraction . 
The aqueous layer of the second extract ion was then mixed with 
two volumes of 9 5  % ethano l ,  and the threaded DNA was spoo led 
out , dried , and dissolved in one vo lume of Tris-EDTA ( T E )  
buf fer ( 1 0 mM Tr is-HCI , p H  7 . 5 ,  1 mM EDTA ) . 
The extract was then digested with 5 0  �g/ml RNase ( S igma ) 
for 4 - 5 hours at 3 7  D C .  The digest was extracted twice with 
phenol /  chloroform and precipitated as descr ibed above and 
disso lved in 2 0 0 - 5 0 0  �l TE ( 1 0 mM Tr is-HCI , pH 7 . 5 ,  1 mM 
EDTA ) . The concentration of the DNA so lution was determined 
with a Beckman spectrophotometer by measur ing ultraviolet 
l ight absorbance at 2 6 0  nm . The final concentration was 
adj usted to 0 . 5  mg/ ml . 
Preparation of  PCR Pr imers 
In order to analyze the mutations which caused 
inact ivat ion of the aprt gene at the sequence leve l , the aprt 
gene was amp l i f ied by the polymerase cha in react ion ( PCR) 
4 0  
technique ( Saiki , e t  a l . , 1 9 8 5 ) . Twenty-mer-ol igonucl eotides 
which are compl imentary to the sequences f l anking each exon of  
the aprt gene were synthes i z ed and used as the pr imers i n  the 
polymerase cha in reaction ( Table 2 ) . Synthes i s  of the 
o l igonucleotides was done at the nucleic acid core fac i l ities 
at the Medical College of Virginia by phosphoramidite method . 
O l i gonuleotides were pur i f ied by ion-pair ing HPLC on a 3 . 8  x 
2 5 0  rom C- 18 co lumn ( Ra inin ultrosphere ODS ) . HPLC grade 
buf fers were f i ltered and degassed prior to use . Buf fer A 
cons isted of 5 % acetonitr i l e , 0 . 1  M tr iethylammonium acetate , 
pH 7 . 0 .  Buffer B cons isted of 5 0  % acetonitr i l e , 0 . 1  M 
triethylaromonium acetate , pH 7 . 0 .  A l inear gradient of 1 0 - 3 0  
% buffer B was appl ied to the column over 6 0  minutes of 
e lut ion time and the maj or ultraviolet-absorbing peak was 
co l lected . Pur i f ied ol igonuc leotides were dried and d i s s olved 
in distil led water . Concentrat ions of the ol igonuc l eotide 
solut ions were determined by measuring the UV absorbance on 
Beckman spectrophotometer and adj usted to 0 . 5  mg/ml . 
Po lymerase Cha in Reaction : 
Exons of the aprt gene that are located in close vicinity 
of each other were amp l i f ied together by the po lymerase cha in 
reaction . Exons 1 and 2 were amp l i f ied in one segment and 
exons 3 ,  4 and 5 were amp l i f ied in another segment . PCR was 
carried out in reaction volume of 1 0 0  � l  
containing 1 � g  of genomic DNA , 0 . 2 5 � g  of each pr imer 
f l anking the exon to be amp l i f ied and 0 . 2  roM of each 
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Table 2 .  Ol igonucleotide Primers Used in Polymeras e  Cha in 
Reactions and Sequenc ing React ions . 
Name Sequence DescriQtion position 
1U : TGTTCCCGGACTGGTATGAC upper strand exon 1 - 6 4 - -4 5  
1 L : AACAAGGAGAGGCTGGTGGC lower strand exon 1 2 0 3 - 1 8 4  
2 U :  GCCACCAGCCTCTCCTTGTT upper strand exon 2 1 8 4 -2 0 3  
2 L :  GGTTGAAGAAAGAAGGGATGG lower strand exon 2 4 2 1-4 0 1  
3 U :  CTTACACCTCAGCCCTAACA upper strand ex on 3 1 2 5 1- 1 2 7 0  
3 L :  GGAAGTAGAGTGAGAGTCTA lower strand exon 3 1 5 7 2 - 1 5 5 3  
4 U :  TAGACTCTCACTCTACTTCC upper strand exon 4 1 5 5 3 - 1 5 7 2  
4 L :  CTCTTGCTTAGACAGCACCC lower strand exon 4 1 7 3 1- 1 7 1 2  
5U : GGGTGCTGACTAAGCAAGAG upper strand exon 5 1 7 1 2 - 1 7 3 1  
5L : CTGGTGGCTCACAAAGGTCA lower strand exon 5 1 9 9 8 - 1 9 7 9  
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deoxynucleos ide triphosphate ( dNTP , Pharmac i a ) . The reaction 
buf f er cons isted of 1 0  roM Tri s-HCI , pH 8 . 3 ,  5 0  roM KCI , 1 roM 
MgC l2 and 5 0  j.£g/ml bovine serum albumin ( BSA , Sigma ) . The 
above mixture was heated to 9 5 ° C  for 5 minutes prior to 
addition of 2 units of Taq po lymerase ( Perkin E lmer-Cetus ) .  
The reaction mixture was overlaid by 5 0  j.£ l  l ight mineral o i l  
( S igma ) t o  prevent evaporation . 
Thirty cyc les of PCR were run on a Perkin E lmer-Cetus 
therma l cycler . Each react ion cyc le was composed of 1 minute 
denaturing time at 9 4 ° C ,  15 seconds ( for exons 3 ,  4 ,  5 )  or 
1 . 5  minutes ( for exons 1 ,  2 )  annea l ing t ime at 5 5 ° C  and 2 
minutes at 7 2  ° C  for po lymer i z ation . The f inal extens ion 
period was 7 minutes at 7 2 ° C .  
S ingle-stranded DNA was obtained by conducting an 
" asymmetric PCR" in which 1 0  j.£ l  of unpur i f ied double-stranded 
PCR product was used as a temp late and 0 . 5  j.£g of one of  the 
two primers was added . Twenty cyc les of reaction were run with 
the same parameters used in regular PCR . Products of 
asymmetric PCR were separated from rema ining nucleot ides and 
primers by prec ipitation with 1 volume of 4 M ammonium acetate 
and 2 volumes of 2 -propanol .  0 . 5  j.£g supercoi led p lasmid DNA 
was added to fac i l itate pel let format ion . Following 10 minutes 
o f  centri fugat ion in a microcentr i fuge , the pel let was washed 
with 70 % ethanol and recentri fuged . The dried pel l et was 
dissolved in 25 j.£l dH20 ,  and used in direct sequencing 
reactions . 
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Agarose Gel E lectrophores i s : 
PCR products were detected by 1 . 5  % agarose gel 
e l e ctrophores i s . 1 . 5  g agarose gel powder was melted in 90 ml  
d i s t i l led water on a hot plate . 1 0  mI l O  x TBE buffer ( 1 0 x 
TBE : 8 9 0  roM bori c  acid , 8 9 0  roM Tr is base , 2 0  roM EDTA) and 5 � l  
( 1 0 mg/ml ) ethidium bromide was added in the g e l  solution . The 
gel solut ion was solidif ied in a gel conta iner . A 9 �l DNA 
samp le was mixed with 1 �l loading solution ( 5 0  roM EDTA , 4 0 % 
sucrose , 1 % bromophenol blue ) and loaded on the gel . The DNA 
samples were electrophoresed in 1 x TBE buf fer at 1 0 0  volts 
for 1 to 2 hours . A Polaroid f i lm picture was taken under 
u ltraviolet l ight to visua l i z e  the DNA bands . 
DIRECT SEQUENCING OF PCR PRODUCTS 
Sanger ' s  Seguenc ing React ion 
coding regions of the aprt gene were sequenced exon by 
exon us ing the dideoxy cha in-terminat ion method ( Sanger ) unt i l  
the mutation was found . S ing le-stranded PCR products were used 
in the sequenc ing reaction . The annea l ing step was carried out 
by combining 7 �l ( 5  pmo l )  temp late DNA , 1 �l ( 5  pmo l )  of the 
o l i gonuc leotide pr imer which annea ls to the s ing le-stranded 
template and 2 �l 5 x reaction buffer ( 5  x reaction buf f er : 
2 5 0  roM Tris-HCI , pH 8 . 8 , 3 5  roM MgC lz ) .  The react ion was heated 
to 7 0 ° C  for 3 minutes and incubated at 42 °C for 10 minutes . 
The polymer i z ation react ion was triggered by adding 2 units of 
Taq po lymerase , 1 � l  a-3zP-dATP ( 8 0 0  C i / mmole , 1 0  �Ci / � l , New 
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England Nuc lear ) and 4 . 5  � l  dH20 .  The above mixture was 
vortexed and used immediately for termination reactions in 
which 4 � l  of the above reaction was transferred to each tube 
containing 4 �l of one of the termination mixes ( each 
termination mix contained 2 0  �M of each dNTP and 60 �M ddGTP 
in G-mix , 8 0 0  �M ddATP in A-mix , 8 0 0  �M ddCTP in C-mix , and 
4 0 0  �M ddTTP in T-mix) . The tubes were incubated at 7 0 ° C  for 
5 minutes before and after 1 �l " chase" ( 2  mM of each dNTP ) 
was added into each tube . The react ion was stopped by addition 
o f  4 � l  formamide-dye stop so lut ion ( 9 5 % deion i z ed formamide , 
2 mM EDTA , 0 . 5  % bromopheno l blue , 0 . 5  % xylene cyanol F F ) . 
Polyacrylamide-urea Gel Electrophore s i s  
Samples of DNA sequenc ing reactions were e lectrophoresed 
on a vertical po lyacrylamide-urea denatur ing gel which 
contained 7 % po lyacrylamide / bisacrylamide ( 2 0 : 1 ) gel in 1 x 
gel buffer ( 1 3 0  mM Tr i s  bas e ,  4 5  mM bor ic acid , 2 mM EDTA) . 
Immediately prior to pour ing the gel , 0 . 6  ml freshly made 0 . 1  
% ammonium persul fate and 4 0  � l  temed were added into 9 0  ml 
gel solution . The samples were denatured at 9 5 ° C  for 5 
minutes before be ing loaded on the sequenc ing gel . The gel  ( 3 5  
x 4 3  x 0 . 0 4 cm ) was run at 8 0  watts for various lengths of 
t ime depending on the size of the DNA fragment . 
SOUTHERN BLOT ANALYS I S  
Preparation of the aprt Probe 
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The 3 . 8  kb Bam H I  insert o f  the p lasmid pHaprt ( Lowy et 
a l . , 1 9 8 0 )  contains the sequences coding for the enzyme APRT . 
The plasmid pHaprt was a gift of R .  Axe l and was amp l i f i ed by 
other members of this laboratory . pHaprt p lasmid ( 2 5 0  � g )  was 
f irst digested with 50 units of the restr iction endonuc leases 
Xmn I ( New England Biolabs ) at 37 °C overnight and was then 
subj ected to a second digestion with 1 2 5  units Bam H I  ( New 
England Biolabs ) at 3 7  ° C  overnight . The effectiveness of  
digestion was monitored by agarose gel e lectrophores i s . DNA 
fragments were separated on agarose gel . The 3 . 8  kb band was 
isolated and the DNA was e lectroe luted in dialysis tubing 
( Fi sher Scient i f i c )  at 5 0  vo lts overnight . TE buffer ( 2 0  roM 
Tris-HCI , pH 8 . 0 , 1 roM EDTA ) was rec irculated between two 
chambers of the electrophores is apparatus during 
e lectroelution . The electr ic current was reversed for one 
minute at the end of the e lution to detach DNA mo lecules from 
the wa l l  of dialys i s  tubing . The DNA was concentrated and 
pur i f i ed on a QIAGEN tip 2 0  according to the manufacturer ' s  
instructions . Fol lowing e lut ion by the high salt solution , the 
DNA was then ethanol precipitated by additions of 2 volumes of 
1 0 0  % ethano l followed by 1 hour of cool ing at -7 0  ° C .  The DNA 
was then spun down in a microcentr i fuge for 15 minutes .  The 
p e l l et was washed with 2 0 0  �l 70 % ethano l ,  dried and 
d i s s o lved in 60 �l dH20 .  The concentration of the DNA solution 
measured on the spectrophotometer was 0 . 3 7 �g/ � l . 
The 3 . 8  kb aprt fragment was label ed with a Bethesda 
Research Laboratories Life Technologies , Inc . ( BRL ) n i ck 
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trans lation system . I n  5 0  � l  reaction volume , 0 . 5  � g  aprt 
fragment was combined with 5 �l solution A2 ( 0 . 2  mM dATP , dGTP 
and dTTP , 5 0 0  mM Tris-HCl , pH 7 . 8 ,  50 mM MgCl2 f 1 0 0  mM 2 -
mercaptoethanol , 1 0 0  �g/ml nuclease-free BSA) , 9 0  � C i  a_TIp 
dCTP ( 1 0 mCi /ml , 3 0 0 0  C i / mmloe ) , 5 � l  solut ion C ( 0 . 4  U / � l  DNA 
Po lymerase I ,  4 0  pg/ � l  DNase I ,  5 0  mM Tris-HCl , pH 7 . 5 ,  5 mM 
Mg-acetate , 1 mM 2 -mercaptoethano l ,  0 . 1  mM PMSF , 5 0  % 
g lycerol , 1 0 0  �g/ml nuclease-free BSA) . The reaction mixture 
was incubated at 1 5 ° C  for 1 . 5  hours and 5 �l solut ion D ( 0 . 3  
M EDTA , pH 8 . 0 ) was added to stop the reaction . The 32p labeled 
probe was pur i f ied on QIAGEN tip 20 followed by ethanol 
prec ip itation and dissolved in 2 0 0  � l  TE buf fer ( 1 0 mM Tris­
HCl , pH 7 . 5 , 1 mM EDTA) . Radioactivity of  the probe ( -2 x 1 08 
cpm / � g )  was measured on a Beckman l iquid scint i l lation 
counter . 
D igestion of Genomic DNA 
For complete digestion , 10 �g genomic DNA was treated 
with 2 0 0  units restr iction endonuc leases Pst I or Bam HI ( both 
from New England Biolabs ) in the buffers provided by the 
manufacturer at 3 7 ° C  overnight . Ethanol precipitation was 
carried out by combining the samples with one tenth volume of 
3 M sodium acetate and two vo lumes of 100 % ethano l .  Fol lowing 
1 hour of cool ing at -7 0 ° C ,  the DNA was spun down in 
microcentr i fuge and the pel lets were washed and dried . DNA was 
d i s s olved in 40 � l  dH20 and 5 � l  loading solution ( 4 0  % 
sucrose , 2 0  mM EDTA , 0 . 1  % bromophenoblue ) .  The samp l e s  were 
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then loaded o n  a 3 6 0  m l  1 % agarose g e l  in TAE buffer ( 4 0  mM 
Tris-acetate , 2 mM EDTA ) conta ining 0 . 5  �g/ml ethidium 
bromide . Also loaded on the agarose gel were 1 ng of the 
unlabe led 3 . 8  kb Bam HI fragment of pHaprt and a 1 kb s i z e  
marker which i s  a mixture of DNA fragments o f  s i z es between 
7 5 0  base pairs and 12 kb . Electrophores i s  was carried out in 
1 x TAE buf fer at 4 0  vo lts for 24 hours . A Polaroid picture of 
the gel was taken under ultraviolet l ight with a ruler p l aced 
on the s ide of the gel so that the distances to which the 
markers migrate could be determined on the picture and in 
turn , the s i z es of the DNA fragments on the blot could be 
estimated . 
Southern Transfer and Hybr idization 
The agarose gel conta ining fractionated DNA samples was 
soaked in 2 0 0  ml 0 . 2 5 N HCI for 1 0  minutes ( acid depurination)  
fol lowed by soaking in 200 ml denaturation solution ( 1 . 5  M 
NaC I , 0 . 5  M NaOH ) twice for 1 5  minutes and in 2 0 0  ml 
neutral i z ation solut ion ( 1 . 5  M NaCI , 1 M Tris-HCI , pH 7 . 4 ) 
twice for 1 5  minutes . 
The buffer used for blotting was 1 0  X SSC ( 1  X SSC : 0 . 1 5 
M NaCI , 0 . 0 1 5  M sodium c itrate , pH 7 . 0 ) . The blott ing stack 
was assembled as follows : one sheet of S & S  GB0 0 3  f i lter paper 
saturated with blotting buf fer was p laced on a glass p late 
with both s ides hanging down and dipping into blotting buf fer 
in the container ; three p ieces of GB0 0 3  f i lter paper cut to a 
s i z e  s l ightly larger than the gel and saturated with blott ing 
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buf f er ; the gel ; Nytran membrane cut t o  the s i z e  of  the gel 
and saturated with blotting buffer ( a ir bubbles under the gel 
and between gel and Nytran membrane were removed ) ;  three 
p ieces of GB0 0 3  f i lter paper saturated with blotting buf fer ; 
and a 1 . 5  inch stack of paper towe l s . On top of the stack , a 
l ight weight was added to keep a l l  layers compressed . Transfer 
was continued at room temperature overnight . The Nytran 
membrane was then soaked in 1 0 0  ml 5 x sse for 5 minutes to 
remove gel particles and baked at 75 °e for 1 hour to 
immob i l i z e  DNA fragments on the membrane . 
The completely dried Nytran membrane was soaked in 2 0  ml 
prehybridization buffer [ 6  x sse , 1 0  x Denhardt ' reagent ( 0 . 2  
% Ficol l ,  0 . 2  % polyvinylpyrro l idone , 0 . 2  % BSA ) , 0 . 5  % sodium 
dodecyl sul fate ( SDS ) , 1 0 0  Mg low mo lecular we ight DNA ] at 4 2  
° e  for 2 hours . 
Hybridizat ion was carried out in a 
container in 3 0  ml hybridizat ion buf fer 
capped plastic 
(50  % deion i z ed 
formamide , pH 7 . 4 ,  6 x sse , 0 . 5  % SDS , 5 0  Mg low molecular 
weight DNA , 8 % dextran sulfate 500 and 1 06 cpm/ml probe ) at 
42 °e overnight . 
The Nytran membrane was subj ected to low and high­
stringency washes : twice for 1 5  minutes each in 100 ml 6 x 
sse , 0 . 2  % SDS at room temperature ; twice for 1 5  minutes each 
in 1 0 0  ml 1 x sse , 0 . 6  % SDS at 37 ° e ;  and once in 1 0 0  ml 0 . 1  
x s s e , 1 % SDS at 6 5  ° e  for 1 hour . The membrane was b lotted 
dry and wrapped in plastic wrap prior to autoradiography which 
was at -7 0  °e with an intens i f ier screen . 
4 9  
IN VITRO DNA CLEAVAGE REACTION 
Nuc l ear Enzyme Extract ion 
CHO-D4 2 2  ce l l s  were grown in a-Minimum Essent i a l  Medium 
supplemented with 1 0  % fetal bovine serum and 5 % horse serum . 
Ce l l s  were ma inta ined in exponenti a l  growth in spinner f lasks 
at 37 · C .  A tota l of 5 x 1 08 cells  in 1 l iter vo lume were 
sedimented and washed three t imes with cold buf fer A ( 0 . 15 M 
NaCI , 1 0  mM KH2P04 , pH 7 . 5 ) . Cells  were suspended in 8 . 7 5 ml 
buf fer G [ 5  mM KH2P04 , 2 mM MgC I2 , 4 mM d ithiothreital ( DTT ) , 
0 . 1  mM Na2EDTA , pH 7 . 0  l ,  and incubated on ice for about 1 0  
minutes unti l  9 0  % of the c e l l s  were stained with trypan blue 
whi le rema ining intact . Ce l l s  were checked every 5 minutes 
under a microscope . The cell  suspension was immediately 
centr ifuged at 400 x g for 5 minutes . The supernatant was 
aspirated , and the pellet was resuspended in 8 ml buf fer H ( 5  
mM KH2P04 , 2 mM MgC lv 4 mM DTT , 0 . 1  mM Na2EDTA , 0 . 2 5 M sucrose , 
pH 7 . 0 ) . The cell  suspens ion was layered over 3 ml of buf fer 
I ( 5  mM KH2P04 , 2 mM MgCI2 , 4 mM DTT , 0 . 1  mM Na2EDTA , 0 . 3  M 
sucrose , pH 7 . 0 ) , and centr i fuged at 2 , 0 0 0  x g for 2 0  minutes . 
The c e l l  pel l et was resuspended in 0 . 5  ml buffer J ( 5  mM 
KH2P04 ,  4 mM DTT , 1 mM Na2EDTA ) , and incubated on ice for 1 5  
minutes . 0 . 5  ml of buf fer L ( 4 0  mM Tris-HCI , 0 . 7  M NaCI , 4 mM 
DTT , 6 0  % g lycerol , pH 7 . 5 ) was added , and vortexed . The c e l l  
suspension w a s  incubated on ice f o r  3 0  minutes and 
u ltracentr i fuged ( Beckman Ti 7 0 . 1  rotor ) at 1 0 0 , 0 0 0  x g for 1 
hour at 4 · C  in an Oak Ridge tube . The supernatant which 
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contains nuclear enzyme topo isomerase I I  was a l i quoted , and 
stored at -7 0 ° C .  The following prote inase inhibitors were 
added to buffers G ,  H ,  I ,  J and L immediately before use : 1 roM 
ben z amidine , 10 J.lg/ml soybean trypsin inhibitor , 5 0  J.l l /ml 
l eupept in , and 1 roM PMSF . 
Test of Nuc lear Enzyme Act ivity 
Supercoi l ed DNA was used as substrate to test DNA 
c leavage activity of the nuc lear extract . The c leavage 
reaction was carried out in 1 0 0  J.ll react ion buffer ( 1 0 roM 
Tris-HC1 , pH 7 . 4 ,  5 0  roM KC1 , 5 roM MgC 12 , 0 . 1  roM EDTA , 1 roM 
ATP ) with 0 . 4  J.lg supercoi led DNA , 1 0  J.lM teniposide and 0 . 5  J.l l  
- 4 J.l l  nuclear extract . The reaction was incubated a t  3 7 ° C  
for 3 0  minutes and terminated by addition o f  SDS and 
proteinase K ( 1  % and 0 . 1  mg/ml ) and incubat ion at room 
temperature for 3 0  minutes . The reaction mixture was 
e l ectrophoresed on an agarose gel to separate DNA in d i f f erent 
forms ( supercoi led , circular , l inear ) wh ich was an indication 
of  c leavage . 
Preparation of DNA Substrates 
To prepare end labeled PCR products of exons 2 ,  3 ,  4 and 
5 of the aprt gene , PCR pr imers f lanking these exons were 5 ' -
32P-end- labe led by the forward reaction . In 3 6  J.l l  reaction 
vo lume , 1 . 5  J.lg each pr imer was mixed with 2 5  J.l l  ( 8 3  pmo l )  �-
32p-ATP ( 3 0 0  C i / mmole , DuPont ) , 3 . 6  J.l l  forward reaction buf fer 
( 0 . 5  M Tris-Cl , pH 7 . 5 ,  0 . 1  M MgC 12 , 50 roM DTT , 0 . 5  
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mg/ml BSA) , 1 � l  1 0 0  mM spermidine , 2 0  units T 4  polynucleotide 
kinase ( Promega ) and incubated at 3 7 ° C  for 1 hour . The 
reaction was terminated by adding 1 �l 0 . 5  M EDTA and heating 
to 7 0 ° C  for 1 0  minutes . Labe led o l igonucleotide primers were 
ethano l-precipitated and dissolved in 30 � l  of dH20 .  
A tota l o f  8 labeled primers were used separate ly to 
generate 8 PCR products of exons 2 ,  3 ,  4 and 5 .  Four o f  them 
had 32p labe l at 5 '  -ends of upper strands and the other 4 
products had 32p label at 5 '  -ends of lower strands . PCR was 
carr ied out in 1 0 0  � l  PCR buffer descr ibed ear l ier with 0 . 2  mM 
each dNTP , 0 . 1  �g pHaprt plasmid ( temp late ) ,  15 � l  label ed 
pr imer and 0 . 2 5 �g unlabeled pr imer of the oppos ite strand . 
The mixture was heated to 9 5 ° C  for 5 minutes before 2 units 
of  Taq polymerase was added and over laid with 5 0  � l  minera l 
o i l  to prevent evaporat ion . Twenty cycles of reaction were 
carri ed out on Perkins E lmer cetus therma l cyc ler , each at 9 4  
° C  for 1 minute , 5 0 ° C  for 1 . 5  minutes , 7 2 ° C  for 1 minute and 
f inal extension period at 72 °C for 7 minutes . 
PCR products were pur i f ied by precip itation with 1 0 0  � l  
4 M ammonium acetate and 2 0 0  � l  2 -propanol . Following 1 0  
minutes of incubation a t  room temperature , the DNA was 
centri fuged in a microcentrifuge for 10 minutes and the pellet 
was washed , dried and dissolved in 17 � l  H20 .  To ensure that 
the substrates were ful l  length mo lecules , the products were 
reacted with 1 �l Klenow fragment and 0 . 5  �l 2 mM dNTP mix at 
3 0 ° C  for 15 minutes . The reaction was stopped by addition of 
1 �l 0 . 5  M EDTA . 
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End labeled PCR products were pur i f ied o n  an 8 % 
polyacrylamide/ bisacrylamide ( 3 0 : 1 )  nondenatur ing gel ( 3 0  x 4 0  
x 0 . 0 8 cm) prepared the same a s  was done for denaturing gel . 
The samples were e lectrophoresed at 3 0  watts for 4 . 5  hours . An 
X-ray f i lm was exposed to the gel for 5 minutes and was used 
to direct isolation of the DNA bands of  interest . I s olated DNA 
fragments were e lectroeluted in dia lys i s  tubes in TE buffer 
( 2 0  roM Tris-HCI , pH 8 . 0 ,  1 roM EDTA) at 5 0  vo lts overnight in 
a hor i z onta l agarose gel box . The buf fer was recirculated 
dur ing e lution . E lectr ic current was reversed for 1 minute 
before the DNA in the dialys i s  tubes was concentrated on 
QIAGEN tip 20 according to manufacturer ' s  instruct ions . 
Fol lowing ethano l prec ipitat ion , the end labeled PCR products 
were disso lved in dH20 to make f inal concentrat ion 
approximately 0 . 0 1 �g/ � l  which was est imated by comparison 
with samples of known concentrat ion on an agarose gel . 
Preparat ion of Pur ine Markers 
Each end labeled PCR product ( 0 . 0 2 �g) was heated to 8 0  
° C  i n  1 0 0  �l  0 . 1  M KCI , 1 0  roM Sod ium citrate , pH 4 . 0  for 7 . 5  
minutes . Following addition of 2 0  � l  1 N NaOH the samp l e s  
were heated to 9 0 ° C  f o r  3 0  minutes . Twenty micro l iters of 
1 N HCI and 5 �g tRNA were added and the samples were ethanol 
precip itated and dissolved in 1 0  � l  H20 and 1 0  �l formamide­
dye so lut ion ( 5 0  % deion i z ed formamide , 2 roM EDTA , 0 . 5  % 
bromophenol blue , 0 . 5  % xylene cyanol FF) . 
5 3  
In vi tro DNA Cleavage React ion and Gel E lectrophore s i s  
The end labeled DNA substrates ( - 0 . 0 2 �g)  were cleaved i n  
v i  tro in the presence of 2 � l  topo i somerase I I  a n d  1 0  � M  
tenipos ide . Topoisomerase I I  used in  thi s  experiment w a s  a 
generous gift from Dr . Y .  Pommier . It was extracted from mouse 
l eukemia ce l l  l ine L12 1 0  and was pur i f ied on HPLC . C leavage 
reactions were carried out in 20 �l react ion buffer ( 0 . 0 1 M 
Tris-HCI , pH 7 . 5 ,  0 . 0 5 M KCI , 5 roM MgC I2 , 0 . 1  roM EDTA , 1 roM 
ATP and 15 �g/ml BSA) at 3 7 ° C  for 1 0  minutes . React ions were 
stopped by addition of SDS , EDTA and prote inase K with f inal 
concentrat ions of 1 % ,  10  roM and 250 �g/ml , respect ive ly , and 
incubat ion at 4 2 ° C  for 1 hour . Cleaved fragments were ethanol 
precipitated and dissolved in var ious vo lumes of formamide-dye 
so lut ion ( 9 5  % deion i z ed formamide , 2 roM EDTA , 0 . 5  % 
bromophenol blue , 0 . 5  % xylene cyanol FF)  depending on the 
yield of prec ipitation . 
The samples were loaded on a 7 % po lyacrylamide-urea 
denatur ing gel and electrophoresed at 80 watts . 
RESULTS 
Ten ipos ide Mutagenes is 
Independent cultures of CHO-D4 2 2  c e l l s  were mutageni z ed 
by tenipos ide at different concentrations for 1 6  hours and the 
c e l l s  were a l lowed to grow for 6 days before undergoing aprt­
mutant selection . Dur ing the 6 days , the APRT enzyme rema ining 
in the cells was di luted by degradat ion as wel l  as c e l l  
divis ion so that the mutant phenotype could be expressed . The 
numbers of 8 -az aadenine resistant mutant colonies in each 
culture were counted at the end of the selection period and 
the mutation frequenc ies were calculated . Concurrent with 
these procedures , a sma l l  fraction of the c e l l s  was taken from 
each culture after the cells were treated with tenipos ide and 
p l ated in norma l medium for determinat ion of ce l l  surviva l .  
The results of teniposide mutagenesis studies are 
presented in Table 3 .  An exponenti a l  drop in cell surviva l was 
observed with increas ing drug concentrations as was expected . 
The frequency of teniposide- induced mutat ions increased in a 
dose-dependent fashion at lower drug doses . However , start ing 
from the doses that caused around 3 0  % c e l l  surviva l , the 
mutation frequency quickly reached a plateau which is about 
5 4  
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Tab l e  3 .  Average Cell  Surviva l and Mutation Frequency 
at the aprt Locus* 
Percent Mutation 
Dose Surviva l F:!::equency 
( �g /ml ) x ± s . e .  ) ( x ± s . e .  ) 
0 1 0 0  ( n=2 2 )  1 . 4  x 1 0-6 ± 0 . 18 ( n=4 5 )  
0 . 0 2 7 2  ± 6 . 6  ( n=9 )  5 . 1  x 1 0-6 ± 1 .  5 6  ( n=9 )  
0 . 0 4 5 0  ± 4 . 1  ( n=2 3 )  8 . 1  x 1 0-6 ± 1 . 4 4 ( n=2 0 )  
0 . 0 6 3 7  ± 3 . 1  ( n=4 5 )  9 . 8  x 1 0-6 ± 1 . 15 ( n=4 8 )  
0 . 0 8 2 7  ± 3 . 6  ( n=3 3 )  1 0 . 2  x 1 0-6 ± 1 . 9 9 ( n=3 2 )  
0 . 1 6 2 0  ± 6 . 2  ( n=1 3  ) 1 0 . 8  x 1 0-6 ± 4 . 2 9 ( n=9 )  
* The exper iments were done under the standard mutagenes i s  
protoco l in which the ce l l s  were treated with tenipos ide for 
16 hours . 
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1 0  f o ld greater than the background ( spontaneous ) mutation 
frequency . 
In the hope of further maxim i z ing the drug- i nduced 
mutation frequency , several experiments were done under 
d i f f erent var iations of mutagenes i s  protocol .  F irst of  a l l , 
s ince it was reported that calc ium dep letion was an effect ive 
measure to protect cells  from drug cytotoxic ity ( Bertrand et 
a l . , 1 9 9 0 ) , the ce l l s  were incubated with EGTA for 4 hours 
f o l lowed by 1 hour drug treatment . However , the result 
indicated that calc ium dep letion did not improve mutabi l ity of  
the c e l l s  at increasing doses of tenipos ide ( Table 4 ) . 
The second attempt was to a l low mutageni z ed c e l l s  to 
multiply in suspension culture us ing sp inner f lasks ( Breimer 
et a l . , 1 9 8 6 ) , so that pro l i feration of the mutant c e l l s  would 
not be inhibited due to c e l l  conf luence as wou ld happen i f  the 
c e l l s  were grown in tissue culture f lasks . The probl em was 
that whi l e  the drug- induced mutat ions were only s l ightly 
increased , the background mutation frequencies were doubl ed or 
trip led . This is in contrast to results of Bre imer et a l . 
( 19 8 6 )  who reported a much lower spontaneous mutation 
frequency for cel ls growing in suspens ion . 
Fina l l y ,  the c e l l s  were synchroni z ed in the presence of 
excess thymidine , so that the cells could be treated in e ither 
GJ or G2 phase of the cell  cycle . However , no s ignif icant 
d i f f erence between the two groups was observed : mutation 
frequencies were approximately the same as for unsynchroni z ed 
cel l s . 
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Table 4 .  Average Cell  Surviva l and Mutation Frequency 
at the aprt Locus 
Under the Condition of Calc ium Depletion 
Percent Mutation 
Dose Surviva l F;:equency 
( JLg/ml ) x ± s . e .  ) ( x ± s . e .  ) 
0 1 0 0  ± ( n=5 )  0 . 5  x 1 0-6 ± 0 . 14 ( n=5 )  
0 . 0 4 9 8  ± 2 . 0  ( n=3 )  6 . 0  x 1 0-6 ± 1 . 5 2 ( n=3 )  
0 . 0 8 1 0 0  ± 0 . 0  ( n=4 )  3 . 2  x 1 0-6 ± 0 . 8 8 ( n=4 )  
0 . 1 6 9 4  ± 4 . 3  ( n=5 )  5 . 8  x 1 0-6 ± 1 .  0 6  ( n=4 )  
0 . 3 2 6 0  ± 4 . 5  ( n=5 )  3 . 5  x 1 0-6 ± 1 . 4 9 ( n=5 )  
0 . 6 4 4 0  ± 8 . 9  ( n=4 )  5 . 0 x 1 0-6 ± 1 .  59  ( n=4 )  
* The exper iments were done under the condition of calc ium 
dep l etion in which the cel l s  were treated with tenipos ide for 
one hour in the presence of EGTA . 
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I n  order t o  verify that the mutagenes i s  protocol we 
adopted was va l id ,  mutation frequencies at the aprt locus and 
at the hgprt locus were compared . hgprt- mutants were s e lected 
with 6 -thioguanine ( Gupta and S ingh , 1 9 8 2 ) . The mutation 
frequency at the hgprt locus was 5 to 1 0 -fold greater than the 
aprt mutation frequency ( Table 5)  and was comparable to values 
obtained for the same locus by other investigators in CRO 
cel l s  ( S ingh and Gupta , 1 9 8 3 ) . Thus , the nature of the aprt 
locus rather than the treatment protocol was probably 
responsible for the relatively low recovery of the tenipos ide­
induced mutants . 
Sequence Ana lys is of the Mutat ions 
aprt- mutants were collected for DNA sequence analys i s . 
Two mutant colonies ( s i sters ) were picked from each 
independently mutageni z ed culture for which the mutation 
frequency of the culture was at least 8 -fold greater than the 
background mutat ion frequency from the same exper iment . 
Mutants formed spontaneously were also isolated . To ensure 
that no colonies derived from a same mutant cel l  were 
inc luded , when the mutat ion was found to be ident ical between 
s i ster mutant c e l l  l ines , one of them wou ld be e l iminated from 
the data pool . 
Cel lular DNA from each mutant stra in was extracted and 
the mutated aprt gene was amp l i f ied by PCR in two segments . 
Each segment contains exons that are located in close vicinity 
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Tabl e  5 .  compari son of the Mutation Frequencies 
at the aprt and hgprt Locus* 
Dose % Surviva l 
aprt M . F .  
x 10-6 
hgprt M . F .  
x 1 0� 
( ",g im l )  ( x ± s .  e . ) ( x ± s .  e . ) ( x ± s .  e . ) 
0 ( n=2 )  1 0 0  0 . 2  ± 0 . 2  5 . 2  ± 4 
0 . 0 4 ( n=3 )  7 4  ± 1 9  5 . 7  ± 3 . 1  3 0 . 7  ± 7 
0 . 0 6 ( n=2 )  7 2  ± 8 8 . 8  ± 7 . 2  5 8 . 0  ± 1 1  
0 . 0 8 ( n=3 )  4 6  ± 1 0  7 . 9  ± 0 . 8  6 2 . 9  ± 2 7  
* The exper iments were done under the standard mutagene s i s  
protocol in which the ce l l s  were treated with tenipos ide for 
16 hours . hgprt mutants were selected in medium conta ining the 
tox i c  pur ine analog 6 -thioguanine . 
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to each other . Exons 1 and 2 were amp l i f ied in one segment and 
exons 3 ,  4 and 5 were amp l i f ied in another segment . peR 
products bearing sma l l  delet ions or insertions could usua l ly 
be detected by agarose gel e lectrophores i s  ( Figure 3 ) . Three 
of  the drug-induced mutants were shown to be insert ions of 
about 1 9 0  to 3 3 0  base pairs . These bigger insertions are 
d i f f icult to ana lyze at the DNA sequence level , because 
insertions of such s i z es could not be proper ly amp l i f ied to 
yield a homogeneous peR product (mutant 30 in Figure 3 )  even 
though a longer extension time was a l l owed in each reaction 
cyc l e . S ince a s ingle-stranded peR product was used in the 
s equencing reaction , when there was no clean regular peR 
product to serve as template , no usable s ing le-stranded peR 
product could be generated to serve as a temp late in the 
sequencing reaction . As a result , the s i z e s  of these 
insert ions were determined by comparing the peR products with 
s i z e  markers on agarose ge ls . Another seven mutants were found 
to have miss ing peR products , which indicated possible large 
deletions or rearrangements .  These mutants were also excluded 
from sequence analys i s  but were subj ected to Southern blot 
analys i s  in order to determine the nature and s i z es of  the 
alterations . For most of the spontaneous and drug- induced 
mutants , the peR products of the aprt gene were able to be 
amp l i f ied further in an asymmetr ic manner where one of  the two 
DNA strands were preferent i a l ly synthe s i z ed . The s ingle­
stranded products obtained from the asymmetric peR were then 
sequenced by Sanger ' s  sequenc ing reaction to reveal the 
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F igure 3 .  PCR products of exons 3 ,  4 and 5 of the aprt gene 
shown on a 1 . 5  % agarose gel . Lanes C are wild type PCR 
products ( 7 4 7  base pairs ) . Lane 20 shows that the PCR product 
of  mutant 2 0t is miss ing . Lane 3 0  shows that mutant 3 0t 
carries a insertion of about 2 9 0  base pairs which was 
est imated by compar ing the migration distance of the mutant 
DNA fragment with that of the wild type DNA fragment on a 
semi - log p lot of 1 kb s i z e  markers . Lanes 12 and 2 5  show that 
mutants 12t and 2 5t carry deletions of 46 and 2 1  base pairs , 
respectively , which was determined by DNA sequencing . 
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mutations ( Figure 4 ) . 
The achievement of successful sequenc ing was bui lt on 
many attempts and fai lures . F irst of  a l l , denatured doubl e  
stranded peR product w a s  used 
however , no sequence banding 
in the sequenc ing react ion ; 
pattern was shown on the 
sequencing gel , which suggested that the peR product quickly 
annea led and the sequenc ing primer could not anneal to the 
doubl e-stranded temp late . When s ingle-stranded template was 
used in the reaction , too many bands were shown on the 
sequenc ing gel , suggesting that the presence of peR pr imers 
probably caused unwanted sequenc ing react ions to occur . 
D i f ferent purif icat ion procedures were tr ied to e l iminate the 
peR pr imers as wel l  as nucleotides in the asymmetr i c  peR 
product . Among them , centr icon ultraf i ltrat ion columns were 
used but s ingle-stranded DNA molecules were found to bind to 
the f i lter membrane ; hydroxyapatite pur i f ication of s ingle­
stranded asymmetr ic peR product was a l so tr ied unsuccessfully . 
F i na l ly , s ingle-stranded peR product was purif ied by co­
precipitation with 0 . 5  �g supercoi led DNA in 1 vo lume of  4 M 
ammonium acetate and 2 volumes of 2 -propanol . 
It was also found that higher qua l ity sequenc ing data 
were obtained i f  an interna l pr imer ( see Table 2 ) , not used in 
the initial peR , was used either for generat ion of the 
asymmetr ic product or for the sequenc ing react ion . 
s i xty e ight teniposide-induced and 4 2  spontaneous mutants 
were analyz ed at the DNA sequence leve l of the aprt gene . 
Thirteen of the spontaneous mutant sequences were generous ly 
6 4  
F igure 4 .  DNA sequence a lterat ions shown o n  the 
polyacrylamide denatur ing gel . Lanes 1 through 5 represent 5 
mutants ana lyz ed . Letters A ,  C ,  T and G t e l l  the nuc leotide 
the bands represent . Lanes 2 show an insertion mutation the 
mutant carr ies ; the arrow at the left shows the beginning of  
the sequence shift due to the insertion . Lanes 5 show a base 
sUbst itut ion mutation the mutant carr ies ; the arrow at the 
right indicates the T � C base sUbst itut ion ( B . S . ) .  
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I nsert ion _ 
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provided by Dr . F .  Austin from the same laboratory . The types 
of  spontaneous and drug- induced mutations are categori z ed in 
Tables 6 and 7 and summari z ed in Tables 8 and 9 ,  respectively . 
Among a l l  types of spontaneous mutat ions , 64 % are base 
substi tut ions . Whi l e  the frequenc ies of transit ions versus 
transvers ions are we l l  balanced , G · C  � A · T  accounts for 7 1  % 
of the trans itions and 3 7  % of tota l base sUbstitutions . 
F igure 5 shows that most of the sUbstitutions targeted amino 
acids which were previous ly recogn i z ed ,  but several 
sUbstitutions took place at s ites where mutations have never 
been detected before . 
Twenty-one percent of the spontaneous mutations are sma l l  
delet ions ranging from 1 t o  2 9  base pairs i n  s i z e . Most o f  
these sma l l  deletions are framed by short direct repeats ; one 
copy of the repeated sequence is inc luded in the deleted 
fragment and the other one is reta ined in the novoj unction . 
Three dupl icat ions were also observed . A cluster of 5 
deletion/dup l ication mutations is located in a region of exon 
5 where a secondary structure could be formed ( Figure 6 ,  the 
second stem-loop structure ) .  
Three of the 4 2  spontaneous mutations were found to have 
norma l sequences of a l l  5 exons . The a ltered structures may 
res ide in the regulatory components outs ide coding regions of 
the gene . Such cases were also encountered by other 
investigators ( Phear et a l . , 1 9 8 9 )  and were d i f f icult to 
exp l a in . 
The spectrum of tenipos ide- induced mutat ions i s  quite 
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Table 6 .  Categor i z ed spontaneous mutat ions . Lower case 
l etters in deletion and insertion mutations represent the 
deleted or inserted DNA sequences . Short direct repeats 
appearing at the ends of deletion mutations are underl ined . In 
the mutant sequence , one copy of the repeat is retained ; thus , 
the actua l endpo ints of the deletion or insertion are 
indeterminate within the repeat , and are arbitrar i ly shown in 
the left most poss ible position . 
6 8  
Type o f  Mutation Locat ion Amino Acids 
stra in Mutation Seguence (b}2 of gene) Re}21acement 
5 8 s  G - C  .... A - T  TGGTG G AGCTG 1 8 4 1 E .... Q 1 5 8  
5 9 s  G - C  A - T  TGGAG G TAAGA 1 6 6 1  SJ 
6 1 s  G - C  A - T  ACTTC C CCATC 5 8  P S 2 0  
6 7 s  G - C  A - T  TCCTG G CCACT 1 6 5 1  A T 1 3 1  
8 5 s  G - C  A - T  TTTAG G TGAGA 8 1  SJ 
8 8 s  G - C  A - T  CACTG G AGGTA 1 6 5 8  G E 1 3 3  
1 0 0 s  G - C  A - T  AACTA G AAATC 1 5 9 1  E K 1 1 1  
1 1 8 s  G - C  A - T  CATCC G GAAGC 1 3 6 6  R Q 8 7  
3 5 _ 6  G - C  A - T  CAGGG G ATTCA 1 3 0 9  G E 6 8  
3 7 _ 6  G - C  A - T  CCTGG G CTGTG 1 3 5 1  G D 8 2  
6 3 s  A - T  G - C  TAGAC T CCAGG 1 3 0 2  S P 6 6  
6 4 s  A - T  G - C  CAGGG A TATCT 2 1 1  D G 2 8  
1 0 3 s  A - T  G - C  GAAGG A CCCCG 2 3 2  D G 3 5  
1 1 0 s  A - T  G - C  AGATG A TCTCC 1 6 4 3  D G 1 2 8  
6 5 s  A - T  C o G GCGCA T CCGCA 3 8  I S 1 3  
9 4 S  A - T  C o G TTCCC A GGGAT 2 0 7 SJ 
9 5 s  A - T  C o G GAGTG A CTGGA 1 9 1 2  stop C 
1 1 5 s  A - T  C o G GCTGG T GGCGC 2 6  V G 9 
3 4 _ 6  A - T  C o G CTGTT T AGGTG 7 8  F L 2 6  
4 1 .  5 A - T  C o G GCTGG T GGCGC 2 6  V G 9 
4 2 _ 1  A - T  C o G GCCTG T GAGCT 1 7 8 9  C W 1 4 0  
8 7 s  G - C  C o G TGGTG G AGCTG 1 8 4 1  E Q 1 5 8  
1 1 6 s  G - C  C o G CCTGG G CTGTG 1 3 5 1  G A 8 2  
4 0 _ 2  G - C  C o G CAGGG G ATTCT 1 3 0 9  G A 6 8  
5 7 s  G - C  T - A  GCAGG C GAGTG 3 17 SJ 
1 1 7 5  
8 9 5  
8 6 5  
4 1 . 3 
1 1 4 5  
6 6 5  
1 0 7 5  
7 8 5  
6 2 5  
4 2 . 2  
4 2 . 4  
4 1 . 1 
3 3 . 6  
1 0 4 5  
6 0 5  
3 9 . 6  
4 2 . 5  
G · C  T · A  CCTGG 
A · T  T · A  GCGCA 
1 bp delet ion 
1 bp delet i on 
5 bp deletion 
9 bp deletion 
1 1  bp deletion 
16 bp deletion 
18  bp deletion 
18  bp deletion 
G CTGTG 1 3 5 1  G V 
T CCGCA 3 8  I N 
7 
GGCGGaATCTG 
4 4  
CGCAGtTTCCC 
3 3  
CGCAGcgcatCCGCAG 
2 9 9  
GCAAGatcgactacATCGCAGG 
1 7 7 5  
AACCAtgtgcgctgccTGTGAGCT 
1 7 8 3  
GCGCTq££tgtgagctgctggGCCAG 
1 8 1 7  1 8 3 7  
TGAGGtggtggag . . .  gagccTGGTGGAG 
1 9 8  
TCTCCttgtt . . .  tatctCGCCC 
3 1 6  3 4 6  
2 9  and 1 bp deletion GCAGGQgagt . . .  ggtcc�CCaCT 
18 2 1  
1 bp dupl ication GGTgSiAGTGT 
1 6 4 2  
4 bp dupl ication AGATGatctCCTGG 
1 7 7 8  1 8 1 7  
3 7  bp dup l i cation CATGTgcgct . . .  gctgaQGTGG 
No change detected 
No change detected 
No change detected 
6 9  
8 2  
1 3  
7 0  
Table 7 .  Categor i z ed teniposide- induced mutat ions . Lower case 
letters in deletion and insertion mutations represent the 
deleted and inserted sequences . Short direct repeats appearing 
at the ends of deletions and insert ions are underlined . In the 
mutant sequence , one copy of the repeat i s  reta ined ; thus , the 
actual endpoints of the delet ion or insert ion are 
indeterminate within the repeat , and are arbitrari ly shown in 
the l eftmost pos s ible position . 
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Type of Mutant Location Amino Acids 
stra in Mutation Seguence (b2 of gene) Re21acement 
4 t  A · T  C · G  TTCCC A GGGAT 2 07 SJ 
l O t  A · T  C · G  CAGGA A CCATG 1 7 7 2  T -+ P 1 3 5  
5 3 t  A · T  C · G  GAGTG A CTGGA 1 9 1 2  stop -+ C 
7 4 t  A · T  C · G  AGATG A TCTCC 1 6 4 3  D -+ A 1 2 8  
8 0t A · T  C · G  TCACC T TAAGT 2 7 7  L R 5 0  
8 1t A · T  C · G  TTAGG T GAGAT 8 2  SJ 
1 6 t  G · C  C · G  GTGAG C CTGGT 18 3 4  S -+ R 1 5 5  
1 8 t  G · C  C · G  GCAGG C GAGTG 3 1 7 SJ 
2 6t G · C  C · G  AAGTG G TTGTT 1 6 3 0  V L 1 2 4  
2 7 t  G · C  C · G  TCCTG G CCAGT 2 6 7 A P 4 7  
7 2 t  G · C  C · G  CCTCC C TAGCT 1 3 2 9  L V 7 5  
7 9 t  G · C  C · G  GGCGA G TGGCC 3 2 0  SJ 
1 4 t  G · C  T · A  TCCCC G ACTTC 5 2  D -+ Y 1 8  
2 1t G · C  T · A  TGGAG G TAAGA 1 6 6 1  SJ 
3 1t G · C  T · A  TGGTG G AGCTG 1 8 4 1 E stop 1 5 8  
7 2 t  G · C  T · A  CTCAG G AGCTG 1 3 3 8  E stop 7 8  
4 8 t  A · T  T · A  CTTCC T GTCTG 1 5 7 3  SJ 
3 2 t  A · T  G · C  TGATC T GCTGG 1 7 9 4  L P 1 4 2  
3 6t A · T  G · C  GGTGG A GCTGA 1 8 4 2  E G 1 5 8  
4 2 t  A · T  G · C  GCCCC T CCTGA 2 2 3  L P 3 2  
4 5t A · T  G · C  CGAGT A TGGCA 1 4 2 0  Y C 1 0 5  
5 4 t  A · T  G · C  ACTCC A GGGGA 1 3 0 5  R G 6 7  
7 5t A · T  G · C  GAAGC T AGGAT 1 8 7 2  L P 1 6 8  
9 2 t  G · C  A · T  CTGAG G TGGTG 1 8 1 7  V M 1 5 0  
6 8 t  G · C  A · T  TTAAG G GCAGA 1 8 5 9  G S 1 6 4  
7 2  
2 3 2  
3 8t 1 bp delet ion AAGGAcCCCGC 
1 8 7 8  
3 3 t 2 bp deletion GGATCagTACCA 
1 6 4 4  
1 0 1t 3 bp deletion ATGATctcCTGGC 
2 9 4  
2 2 t  4 bp deletion TGGCGgcaaQATCG 
2 7 3  
8 3 t  4 bp deletion CAGTCacctTAAGT 
1 8 0 1  
3 t  6 bp deletion TGGGCgggctaCAGGC 
1 8 7 7  
7 6t 6 bp deletion AGGATcagtacCATTC 
1 5 8 5  
5 2 t  7 bp deletion GGCTGaactagaAATCC 
1 2 9 4  
2 4 t  8 bp deletion ACAGGCctagactCCAGG 
1 8 7 5  
5 5 t  9 bp deletion CTAGGatcagtaccATTCTTC 
1 8 6 3  
3 3 t 1 0  bp deletion GCAGAg£gaagctagGATCAGT 
2 6 9  
7 3 t  1 0  bp deletion TGGCCagtcaccttaAGTCcA 
2 7 7  
9 6t 12 bp deletion CACCT�aagtccacgcaTGGCG 
1 5 8 4  
7 1t 14 bp delet ion AGGCT�ctagaaatccaGAAAGAC 
1 3 8 7  
1 3 t  1 5  bp deletion CCAGG£cccacagtgtcagc�TCCT 
1 6 5 0  
2 9 t  1 6  bp deletion TCCTGgccactggaggtaagaGCCACT 
1 3 3 9  1 3 5 8  
4 9 t  1 8  bp deletion CAGGA�gg . . .  tgtgtGCTCA 
17 3 9  
2 5t 2 1  bp deletion GAGT�gcagc • . .  cgcaTCCGCA 
5 6t 3 6  bp deletion 
1 2 t  4 6  b p  deletion 
1 8 7 4  1 9 0 7  
GCTAG�tca . . .  tgagtGACTGGA 
7 2  1 1 9  
GCGTG£tg . . .  ttcCTGGGCTC 
4 4 t  About 2 2  bp deletion in exon 5 
l lt 1 bp dup l ication 
15t 1 bp dupl ication 
3 9 t  2 bp dupl ication 
9 1t 2 bp dup l i cation 
5t 4 bp dup l ication 
1 6 5 5  
GCCACtGGAG 
1 6 5 5  
GCCACtGGAG 
1 7 7 8  
CATGTgcGCTGCCT 
1 4 1 1  
TATGCtcTCGAG 
1 5 9 5  
GAAATccagAAAGA 
1 3 6 0  
2 3 t  4 bp dupl ication GTGCT£atc�GGAA 
1 8 4 8  
2 8t 4 bp dup l i cation CTGACctcaCTTAA 
1 3 5 2  
3 4 t  4 bp dupl ication TGGGCtgtgTGCTC 
2 6 9  
3 7 t  1 0  bp dup l ication GCCagtcaccttaAGTCCA 
2 1 6  2 5 8  
7 3  
1t 41 bp dup l ication TATCTcgcccctcctg . . .  atcCGCCTCCTG 
9 0t 8 5  bp complex dup l ication in exon4 
3 5t 3 bp insertion 
3 3 t  6 bp insertion 
1 8 5 7  
CTTAAgtt�GGCA 
1 9 0 0  
TCCTGcaatgaCAATATGA 
4 0t About 1 9 0  bp insert ion in exon 3 ,  4 ,  5 
3 0t About 2 9 0  bp insert ion in exon 5 
9 8 t  About 3 3 0  bp insertion in exon 5 
Tab l e  8 .  spectrum of Spontaneous Mutations 
at the aprt Locus 
Type of Mutation Number % 
Trans itions : 
G ' C  A ' T  1 0  2 3 . 8  
A ' T  -+ G ' C  4 9 . 5  
Transvers ions : 
A ' T  e ' G  7 1 6 . 7  
G ' C  e ' G  3 7 . 1  
G ' C  T ' A  2 4 . 8  
A ' T  -+ T ' A 1 2 . 4  
Sma l l  Deletions : 9 2 1 . 4  
Insertions : 3 7 . 1  
No Change : 3 7 . 1  
Tota l : 4 2  1 0 0  
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Tab l e  9 .  
or 
Spectrum of Tenipos ide-Induced Mutations 
at the aprt Locus 
Type of Mutat ion Number % 
Trans itions : 
A · T  G · C  6 8 . 8  
G · C  -+ A · T  2 2 . 9  
Transversions : 
A · T  e · G  6 8 . 8  
G · C  e · G  6 8 . 8  
G · C  T · A  4 5 . 9  
A · T  T · A  1 1 . 5  
Sma l l  Deletions : 2 0  2 9 . 4  
Insert ions : 1 6  2 3 . 5  
Large Deletions 
Rearrangements :  7 1 0 . 3  
Tota l : 6 8  1 0 0  
7 5  
7 6  
F igure 5 .  Di stribut ions of amino acid rep lacements resulting 
from base sUbstitution mutations at the aprt gene . The amino 
acid displacements resulting from spontaneous mutations 
labe led above the APRT sequence were reported previous ly by 
other investigators ( de Boer and G l i ckman , 1 9 9 1 ) . The amino 
acid rep lacements resulting from spontaneous ( lower case 
letters ) and teniposide- induced mutations labeled below the 
APRT sequence were results from th is study . 
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F igure 6 .  Regions of dyad symmetry at the aprt locus where 
secondary structures could be formed . The upper hair pin 
structure i s  in exon 3 and the lower ones are in exon 5 .  
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d i f f erent from that of spontaneous mutations . S i xty-three per 
cent of the mutations are deletions , insertions and 
rearrangements of different s i z es . Tenipos ide- induced sma l l  
delet ions are s imilar in nature t o  the deletions formed 
spontaneously . The s i z es of these sma l l  deletions are spread 
evenly between 1 and around 20 base pairs with the exception 
of  two deletions of 36 and 46 base pairs . The presence of  
short direct repeats at the ends of the deletions i s  a l so 
characteristic of this group . There is a c luster of 4 
deletions at exon 5 where the sequence is rich in short direct 
repeats and long stretch of dyad symmetry ( Figure 6 ) . These 
deletions (mutants 3 3 t ,  55t , 5 6t ,  7 6t )  beg in between base 
pairs 1 8 6 5  to 18 7 9 , which is around the base of a putative 
stem- loop structure . 
Over two thirds of the tenipos ide- induced insertions are 
dupl i cations and most of them are 4 base pairs or less . The 
insertions are e ither as sma l l  as 3 and 6 base pairs or as 
large as about 190 to 3 3 0  base pairs . The s i z e s  of the three 
large insertions were est imated on agarose gel s ince no 
sequence data are ava i lable . 
The composition of teniposide- induced base subst itut ions 
is somewhat different from that of spontaneous substitutions . 
Transvers ions were over two t imes more frequent than 
transitions and G · C  A · T  transitions were much less 
preva l ent . However , s imilar to the spontaneous ones , 
tenipos ide- induced base sUbst itut ions were rather evenly 
d istr ibuted throughout the coding sequences and sp l ice 
8 �  
j unctions o f  the aprt gene ( F igure 5 ) . 
Southern Blot Ana lys i s  of Large Scale Mutations 
Among 6 8  tenipos ide- induced mutations , 7 of them have at 
least one exon which f a i l ed to be amp l i f ied by PCR . These 
mutations were examined by combined PCR and Southern blot 
analys i s . The observed abnorma l ities are l i sted in Tabl e  � O . 
Restriction endonuc leases Bam HI and Pst I were used to 
d igest mutant DNA ( p lease refer to Figure 2 for restr iction 
s ites ) . After DNA fract ionat ion by agarose gel electrophoresis 
and Southern transfer , the DNA was hybridi z ed with a 
homogeneously 32p labe led 3 . 8  kb Bam HI fragment of the plasmid 
pHaprt . Wild type DNA digested with Bam HI showed a 3 . 8  kb 
band which conta ins the ent ire coding sequences of the aprt 
gene ( Figure 7 ) . Pst I cuts the aprt gene into 2 segments . A 
3 . 8  kb band contains exons � ,  2 and 3 and a 2 . 0  kb band 
contains exons 4 and 5 ( Figure 8 ) . Changes in banding patterns 
provided clues for determin ing the nature and s i z e  of  a 
mutat ion . Large deletions or rearrangements were indicated in 
these mutations ( Table � O ) . 
Mutants 6t and at seem to have s imi lar a lterat ions . Both 
have fa int or miss ing PCR products for exons � and 2 which 
loca l i z ed the a lterat ions in th i s  region of the gene . 
Displacements of 3 . 8  kb Pst I bands by sma l l er bands indicated 
large delet ions . The fact that the 3 . 8  kb Bam HI  bands are 
displaced by larger bands suggested that the large deletions 
Table 1 0 . PCR and Southern Blot Ana lys is of Large Deletions and Rearrangements 
Southern Blot Analys is 
PCR 
:train s Ana lys is Bam HI s ite Pst I s ite Probable Lesion 
6t Weak exon 1 - 3 . 8  kb band - 3 . 8  kb band Deletion/ rearrangement 
no exon 2 + 3 . 8 5 kb band + 1 . 4  kb band involving exons 1 and 2 
8t Weak exons 1 - 3 . 8  kb band - 3 . 8  kb band Deletion/ rearrangement 
and 2 + 6 . 8  kb band + 1 .  5 kb band invo lving exons 1 and 2 
2 0t No exons 3 ,  - 3 . 8  kb band - both bands About 7 5 0  bp deletion 
4 and 5 + 3 . 0 5 kb band + 5 . 2  kb band at exons 3 ,  4 and 5 
4 6t No exons 3 ,  4 - 3 . 8  kb band - both bands Deletion of most or a l l  
weak exons 1 ,  of the gene 
2 and 5 
S It No exon 4 - 3 . 8  kb band + 2 . 3  kb band Deletion/rearrangement 
+ 2 . 8  kb band invo lving exon 4 
7 0t No exons 3 ,  4 - 3 . 8  kb band - 3 . 8  kb band Deletion/ rearrangement 
weak exons 1 ,  + 3 . 3 5 kb band invo lving most or a l l  
2 and 5 of the gene 
7 7 t  N o  exon 5 - 3 . 8  kb band - 2 . 2  kb band Deletion/ rearrangement 
+ 4 . 1  kb band + 6 . 0  kb band involving exon 5 
Symbols - and + represent loss and gain , respectively . 
(» 
l\J 
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F igure 7 .  Southern blots o f  DNAs digested with the restr iction 
endonuclease Bam HI . Arrows indicate bands of d i fferent s i z e s  
in kb . Lane c :  w i l d  type genomic DNA . Lane M :  3 . 8  k b  aprt 
fragment marker . Due to the differences in the amount of DNA 
loaded on the agarose gel , the marker fragments migrated 
s l ower than genomic DNAs of the same s i z e . 
Q
 
II
I 
0-II
I 
Q
 
..
.. 
..
.. 
..
.. 
00
 
Q
 
N
 
CD
 
�
 
en
 
�
 
U
 
�
 
,. 
84 
II
I 
"! 
"! 
..,
 
N
 
tt 
"! CD I 
8 5  
F igure 8 .  Southern blots of DNAs digested with the 
restriction endonuclease Pst I .  Arrows indicate bands of 
d i f f erent s i z es in kb . Lane c :  wild type DNA . The other lanes 
with d i f f erent numbers represent the tenipos ide- induced 
mutants of the same number . 
In
 
0
 
"
 
u
 
"
 
"
 
t 0 tD 
N
 
iii , 
CD
 
co
 
0
 
N
 
U
 
CD
 
., 
t 
t 
co
 
0
 
..; 
N 
t co ,.; 
t C! N 
In
.,
 
,.:
..:
 
"
 
86 
8 7  
might have e l iminated the upstream Bam HI s ite . The peR and 
S outhern blot results of mutant 20 are consistent and c l early 
indicate a deletion at exons 3 ,  4 and 5 of  about 7 5 0  base 
pairs including the internal Pst I s ite . Mutant 4 6t has a lmost 
everything miss ing except for some faint peR products o f  exons 
1 ,  2 and 5 .  Thi s  could have resulted from deletion of most or 
a l l  of  the gene . However , s ince some of the peR products were 
visible , although barely detected , it could a l s o  be 
interpreted as a bad preparation of  cel lular DNA which 
prevented detection of the mutat ion . Mutant 51t has a miss ing 
peR product when exons 3 ,  4 and 5 were amp l i f ied together . But 
when they were amp l i f ied separate ly , only exon 4 was miss ing . 
Displacement of 3 . 8  kb Bam HI fragment by a 2 . 8  kb fragment 
made the mutat ion seem l ike a 1 kb deletion at exon 4 .  
However , the s i z e  of the entire fragment of exons 3 ,  4 and 5 
i s  only about 7 0 0  base pairs . In add it ion , the extra 2 . 3  kb 
band on the Pst I blot is also d i f f icult to explain in terms 
of a s imple deletion . A rearrangement of the gene structure 
involving exon 4 ,  for example , a very large insertion in thi s  
exon , is  more l ikely t o  b e  the cause . Mutant 7 0t h a s  a n  
ambiguity s imilar t o  that of  mutant 4 6t .  It could e ither be a 
deletion of most or a l l  of the gene or bad preparat ion of the 
cel lular DNA . The alterat ion of mutant 7 7 t  is apparently 
located toward the end of the gene . It is  l ikely to be a large 
delet i on or rearrangement invo lving exon 5 and the downstream 
Bam HI and Pst I restr ict ion s ites . 
Although most of these mutat ions were not ana lyzed in 
8 8  
deta i l , i t  is certain that such large sca le a lterat ions only 
occurred among teniposide- induced mutat ions . 
In vi tro DNA Cleavage 
Drug- induced mutations are probably the result of  
incorrect repair following DNA damages . To try to understand 
the sequence speci f i c ity of drug- induced DNA les ions and the 
cel lular repair mechani sms , it was hoped that with the same 
spec i f icity , DNA strand breaks could be generated in vi tro in 
the presence of topo isomerase II and tenipos ide . 
PCR products of exons 2 ,  3 ,  4 and 5 were 5 ' -end label ed 
with 32p separately in upper and lower strands so that a total  
of  8 substrates were prepared . s ince few deletion/ insertion 
mutat ions were found at exon 1 ,  thi s  fragment was not prepared 
for in vi tro cleavage reaction . 
We f irst attempted to use a crude nuclear extract 
prepared from the CHO-D4 2 2  ce l l  l ine to cata lyze in vi tro 
c leavage reaction . Although DNA c leavage was achieved at exon 
4 as is shown in Figure 9 ,  at other exons , s igni f icant 
c leavage was either not clearly observed or accompanied by a 
high nonspecific background c leavage . Pur i f ied topo isomerase 
II o f  mouse L12 1 0  ce l l s , wh ich was provided by Dr . Y .  Pommier , 
exhibited higher activity and spec i f i c ity in the DNA c leavage 
react ion . Pictures shown in Figures 1 0 , 1 1 , 12  and 13 were 
results of  in vitro c leavage reaction cata ly z ed by pur i f ied 
mouse topoi somerase I I . 
8 9  
Figure 9 .  In vi tro DNA c leavage mediated by crude nuc lear 
extract in the lower strand of exon 4 of the aprt gene . Lanes 
1 ,  2 ,  3 and 4 :  cleavage reactions in the presence of 10 �M 
teniposide and increas ing amount of extract ( 0 . 5  - 3 � l ) . Lane 
T :  reaction with 10 �M teniposide only . Lanes 5 and 6 :  
reactions with extract only ( 1  and 2 � l ) . Lane C :  reaction 
with substrate only (without teniposide and extract ) . 
9 0  
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F igure 1 0 . In vi tro DNA cleavage i n  the upper ( le f t )  and 
lower ( right ) strands of exon 2 of the aprt gene . Lane M :  
pur ine markers . Lane 1 :  cleavage reaction with 1 0  �M 
tenipos ide and 2 �l pur i f ied topoisomerase I I . Lane 2 :  
reaction with 1 0  �M teniposide only . Lane 3 :  react ion with 2 
� l  topoisomerase I I  only . Solid and open triang les indicate 
strong and weak cleavage s ites that were arbitrarily def ined . 
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F igure 1 1 . In vi tro DNA cleavage i n  the upper ( left)  and 
lower ( r ight ) strands of exon 3 of the aprt gene . Lane M :  
pur ine markers . Lane 1 :  c leavage reaction with 1 0  �M 
teniposide and 2 �l pur i f ied topoi somerase I I . Lane 2 :  
react ion with 1 0  �M teniposide only . Lane 3 :  reaction with 2 
� l  topoisomerase I I  only . Solid and open triangles indicate 
strong and weak cleavage s ites that were arbitrar i ly def ined . 
.. 
• 
M 1 2 3 
94 
M 1 2 3 
9 5  
Figure 1 2 . In vi tro DNA cleavage i n  the upper ( left ) and 
lower ( r ight ) strand of exon 4 of the aprt gene . Lane M :  
pur ine markers . Lane 1 :  cleavage reaction with 1 0  �M 
teniposide and 2 �l purif ied topo isomerase I I . Lane 2 :  
reaction with 1 0  �M teniposide only . Lane 3 :  reaction with 2 
� l  topoisomerase I I  only . Solid and open triangles indicate 
strong and weak cleavage s ites that were arbitrar i ly def ined . 
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F igure 1 3 . In vi tro DNA cleavage i n  the upper ( left ) and 
lower ( r ight ) strands of exon 5 of the aprt gene . Lane M :  
pur ine markers . Lane 1 :  cleavage reaction with 1 0  �M 
tenipos ide and 2 �l pur i f ied topo isomerase I I . Lane 2 :  
reaction with 1 0  �M teniposide only . Lane 3 :  reaction with 2 
� l  topo isomerase I I  only . Solid and open triangles indicate 
strong and weak cleavage s ites that were arbitrar i ly defined . 
The l etter N indicates the nonspec i f i c  cleavage . 
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Each labe led substrate was incubated wi th 2 
9 9  
/.1 1  
topoisomerase I I  and 1 0  /.1 M  tenipos ide which stab i l i z ed the 
DNA-topo isomerase II complexes . Subsequent treatment with SDS 
resulted in DNA strand breaks and the broken fragments were 
visua l i z ed by po lyacrylamide-urea gel e lectrophores i s  ( F igures 
1 0 , 1 1 ,  12 and 1 3 ) . Purine markers were run a long with the 
sampl e  DNAs so that the breakage s ites could be located . S ince 
a DNA fragment cut by topoisomerase II has a hydroxyl group at 
the 3 '  end , whi le the correspond ing purine marker has a 
negat ively charged phosphate at the 3 '  end , the topo isomerase 
II c leaved fragment migrates slower than the marker fragment 
of the same length on the sequencing gel . The shorter the 
fragment , the bigger the d i f ference is . For example , a 7 0  base 
pair topo isomerase I I  cleaved fragment appear ing on the gel is 
retarded from the corresponding marker fragment by a d istance 
equivalent one ha l f  of a base , and a 30 base pair fragment is 
retarded by a distance of a comp lete base . Th is difference was 
ver i f ied by treating the pur ine marker with the 3 '  phosphatase 
act i vi ty of T4 po lynuc leotide kinase to remove its 3 '  end 
phosphate ; however , s ince th is remova l seldom went to 
comp letion , it was not rout inely emp loyed . 
Based on the intens ity of the bands , the breakage po ints 
were arbitrar i ly classif ied into strong and weak s ites . A 
total of 3 1  strong s ites and 2 5  weak s ites were detected as 
indicated by s o l id and open triangles in both the gel p i ctures 
and F igures 14 , 1 5 , 16 and 17 , in wh ich sequences of  exons 2 ,  
3 ,  4 and 5 were shown . There are several areas in the gel ( the 
l O O  
F igure l 4 . Map of  teniposide- induced in vitro topo isomerase 
I I  c leavage s ites and deletion/ insertion mutations at exon 2 
of the aprt gene . Open and solid triangles indicate weak and 
strong c leavage s ites that were arbitrar i ly def ined . 
continuous and broken l ines represent deletions and 
dup l ications , respectively . S ince short direct repeats appear 
at nearly a l l  of the deletion and dup l ication termini and one 
of the repeated sequences is reta ined , the endpoints are 
indeterminate within the repeats and both of them are shown 
with extended l ines . 
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F igure 1 5 . Map of teniposide- induced i n  vi tro topo isomerase 
II c leavage s ites and deletion/ insert ion mutations at exon 3 
of the aprt gene . Open and solid triangles indicate weak and 
strong cleavage s ites that were arbitrar i ly def ined . 
cont inuous and broken l ines represent deletions and 
dup l i cations , respectively . s ince short direct repeats appear 
at near ly a l l  of the deletion and dupl ication termini and one 
of the repeated sequences is reta ined , the endpo ints are 
indeterminate within the repeats and both of them are shown 
with extended l ines . 
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F igure 1 6 . Map of teniposide- induced i n  vi tro topoisomerase 
II c leavage s ites and deletion/ insert ion mutations at exon 4 
of the aprt gene . Open and solid triangles indicate weak and 
strong cleavage s ites that were arbitrar i ly def ined . 
cont inuous and broken l ines represent deletions and 
dup l ications , respectively . S ince short direct repeats appear 
at nearly a l l  of the deletion and dupl ication termini ,  and one 
of  the repeated sequences is retained , the endpo ints are 
indeterminate within the repeats and both of them are shown 
with extended l ines . 
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F igure 1 7 . Map of teniposide- induced i n  vi tro topoisomerase 
II cleavage s ites and deletion/ insertion mutations at exon 5 
of the aprt gene . Open and solid triangles indicate weak and 
strong cleavage s ites that were arbitrar i ly def ined . 
cont inuous and broken l ines represent deletions and 
dup l ications , respectively . s ince short direct repeats appear 
at nearly all of the deletion and dup l i cation termini , and one 
of  the repeated sequences is retained , the endpo ints are 
indeterminate within the repeats and both of them are shown 
with extended l ines . 
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f irst 2 0  nuc1eotides a t  the lower strand in exon 2 ,  the f irst 
1 4  nuc leotides at the lower strand in exon 3 and the last 14 
nucleotides at the upper strand in exon 5) where the 
background i s  too high to show DNA c leavage s ites . As a 
result , mutations within these areas (mutants It , 2 4 t , 5 6 t )  
c a n  not b e  ana lyz ed with certainty . 
In order to determine whether sequence co-spec i f i c ity 
between in vi tro c leavage s ites and putat ive init i a l  DNA 
l e s i ons is present in this study , teniposide- induced deletions 
and dup l ications were also i l lustrated in Figures 1 4 , 1 5 , 1 6  
and 1 7  by continuous and broken l ines , respect ive ly . s ince 
many of the deletions and dup l i cations have a short direct 
repeats at the ends , it was impossible to decide at which base 
pair a deletion or dupl ication began . So , extended l ines were 
drawn to inc lude both of the repeated sequences .  
Some of the mutations were clearly assoc iated with in 
vi tro cleavage s ites . However , the s ignif icance of such a 
relationship was not exclus ive and needed to be dist ingui shed 
from possible random coinc idence . Two d i f ferent ana lyses were 
done to ful f i l l  thi s  task . The bas ic assumpt ions behind these 
analyses were that teniposide mediated DNA strand breaks were 
the initial les ions and that the in vi tro c leavage s ites , to 
some extent , represent the DNA breakage po ints in the c e l l s . 
The f irst approach emphas i z ed on the relat ive association 
o f  the teniposide- induced mutat ions within the strong and weak 
s ites . As was described earl ier , the in vi tro c leavage s ites 
were arbitrar i ly classif ied into 31 strong s ites and 25 weak 
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s ites . The number of strong o r  weak s ites within and at the 
end ( s )  of each mutation sequences ( including both repeated 
s equences ) were summed and d ivided by the tota l number of  base 
pairs of a l l  the mutations ( including both repeated 
s equences ) .  The random background was determined by d ividing 
the tota l numbers of strong or weak s ites by the total number 
of base pairs in exons 2 ,  3 ,  4 and 5 .  The non-random 
background was determined by dividing the number of the strong 
or weak s ites by the tota l number of base pairs in the 
mutation-free sequences .  
Table 1 1  shows that the association between strong s ites 
and the mutant sequences is more than 2 times greater than the 
random background and 17 times greater than the non-random 
background . On the other hand , the association between the 
weak s ites and the mutant sequences is not s igni f icantly 
d i f f erent from either of the backgrounds . 
The second analys is is to compare the mutant association 
with the strong cleavage s ites between tenipos ide-induced and 
spontaneous mutations . As is shown in Table 12 , 82 % of  the 
tenipos ide- induced mutants , wh i l e  only 2 2  % of the spontaneous 
mutants that f e l l  into exons 2 ,  3 ,  4 and 5 conta in strong 
c leavage s ites . F ive of the 9 spontaneous deletion / dup l icat ion 
mutations are clustered in a region of exon 5 ( F igure 1 8 )  
where n o  double cleavage s ites are observed . 
Table 1 1 . Association Between in vitro strong and Weak 
C leavage s ites and the Deletion / Dupl ication Sequences * 
strong s ite Weak s ite 
Mutant Sequence : 0 . 1 6 0  0 . 0 7 2  
Total Coding Sequence : 0 . 0 6 7  0 . 0 5 4  
Non-mutant Sequence : 0 . 0 0 9  0 . 0 5 2  
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* The i n  vi tro cleavage s ites were arbitrar i ly clas s i f ied 
into 3 1  strong s ites and 25 weak s ites . The association 
between strong or weak cleavage s ites and the mutant sequences 
were calculated by divid ing the total number of strong or weak 
s ites within and / or at the end ( s )  of the deleted and 
dup l icated sequences ( 4 9  strong s ites and 22 weak s ites ) by 
the tota l number of  base pairs in these sequences including 
repeats at the termini ( 3 0 6 base pairs ) . The random background 
was calculated by divid ing the tota l number of strong or weak 
s ites ( 3 1  strong s ites and 25 weak s ites ) by the tota l number 
of base pairs in exons 2 ,  3 ,  4 and 5 ( 4 6 3  base pairs ) . The 
non-random background was calculated by dividing the tota l 
number of strong or weak s ites within the non-mutant sequences 
( 2  strong s ites and 1 1  weak s ites ) by the tota l number of  base 
pairs in these sequences ( 2 1 2 base pairs ) . 
Table 1 2 . Comparison of Association with strong in vitro 
C leavage s ites Between Tenipos ide-Induced and Spontaneous 
Mutant Sequences* 
Tota l mutations : 
Mutat ions associated 
with cleavage s ite : 
Tenipos ide­
Induced 
2 8  
2 3  
8 2  % 
Spontaneous 
9 
2 
2 2  % 
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* Twenty-eight tenipos ide- induced and 9 Spontaneous deletion 
and dupl ication mutations were recovered in exons 2 ,  3 ,  4 and 
5 .  Twenty-three tenipos ide-induced , but only 2 spontaneous 
deletions / dupl icat ions are assoc iated with strong in vi tro 
c leavage site ( s ) . 
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F igure 1 8 . A cluster of spontaneous deletions and 
dup l ications at exon 5 of the aprt gene . cont inuous and broken 
l ines represent deletions and dupl ications , respectively . Open 
and s o l id triangles indicate topo isomerase I I  mediated weak 
and strong cleavage s ites that were arbitrar i ly def ined . A l l  
of the delet ions and dup l ications are framed b y  a short direct 
repeats and one of the repeated sequences is reta ined . S ince 
the endpoints are indeterminate within the repeats , both of 
them are shown with extended l ines . Region of a putative hair 
pin structure is also shown on the map . 
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DI SCUSSION 
Mutab i l ity of the aprt locus by tenipos ide 
Tenipos ide mutagenes i s  has been studied at the tk locus 
in mouse lymphoma cells  ( DeMar ini et a l . , 1 9 8 7 ) , the hgprt 
locus in CHO cel l s  ( S ingh and Gupta , 1 9 8 3 )  and the aprt locus 
in CHO-D4 2 2  cel l s . The mutagenic responses at these loci to 
tenipos ide are different by more than two orders of magnitude . 
The maximum mutation frequency at the aprt locus is about 1 0  
t imes lower than that a t  the hgprt locus and about 3 0 0  t imes 
lower than that at the tk locus . D i f ferent mutagenic responses 
at d i f ferent genet ic loci to strong clastogens has been 
not iced previous ly ( DeMarini et a l . , 1 9 8 7 ) . It had also been 
observed that in the mouse lymphoma cel l s , the ma j ority of  the 
tk- colonies formed following treatment of a strong clastogen 
such as m-AMSA were sma l l -s i z e  colonies (Moor et a l . , 1 9 8 5 ) . 
The frequency of the large tk- colonies was comparable to the 
mutation frequency at the hgprt locus ( Pommier et a l . , 1 9 8 5 ) . 
It was proposed that large colony tk mutants represent s ingl e  
gene mutations which is probably also the type of  mutation 
recovered at the hgprt locus following treatment of  a strong 
c lastogen . Sma l l  colony tk mutants , on the other hand , appear 
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to result from chromosoma l events in which some o f  the 
surrounding genes that are essent i a l  for cell  growth might 
have been af fected ( Hoz ier et a l . , 1 9 8 5 ) . The heterozygous 
nature of the tk locus enabled the recovery of sma l l  colony 
mutants s ince loss of the essent i a l  genes due to the l arge 
sca l e  a lterations could be part i a l ly compensated by funct ional 
a l leles on the other copy of chromosome 1 1  (which i s  the 
chromosome bear ing the tk gene ) resulting in viable but s l owly 
growing cel l s . However , for the hemizygous hgprt locus , loss 
o f  adj acent essential genes wi l l  lead to cell death . Thi s  
hypothes i s  was strongly supported b y  the observation that in 
a mouse lymphoma c e l l  l ine in which one of the two chromosome 
11 homologues was lost , m-AMSA mutation frequency was reduced 
to the level that was observed at the hgprt locus ( Evans and 
Menc l , 1 9 8 6 ) . 
The same rationa le appears to dictate the mutabil ity of  
the aprt gene in CHO-D4 2 2  cells as wel l .  Based on Southern 
blot analys is , thi s  cell l ine carr ies a deletion of one copy 
of  the aprt gene , rendering it hemi zygous at thi s  locus 
( Na lbantoglu , et a l . , 1 9 8 3 ) . This  i s  presumably the ma in 
reason that wou ld explain the low teniposide mutation 
frequency at the aprt locus . Such results a l so supported the 
idea that teniposide is a strong clastogen . 
The hgprt gene is 4 4  kb wh ich is about 2 0 -fold larger 
than the aprt gene . Thi s  is probably one of the factors , i f  
not the only factor , which caused the 1 0 -fold d i f ference i n  
tenipos ide- induced mutation frequencies between these loci . 
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Due t o  the low level of  aprt mutation frequency , the 
recovery of aprt" mutants tends to f luctuate more between 
rep l icate culture samples . cultures with no mutant recovery 
are not uncommonly seen , which resulted in larger standard 
errors in mutagenes i s  data . On the other hand , cultures with 
very h igh mutant recovery ( for example , mutation frequencies 
around 5 0  x 1 0�) were occas iona l ly observed , and such data 
were exc luded from the data pool s ince these mutants were 
l ikely to be the progeny of preexist ing aprt- ce l l s  which 
e i ther were present in the initial inoculum or arose 
spontaneously short ly thereafter . 
The most va luable mer it of th is system is that the 
hemizygos ity and sma l l  s i z e  of the locus enabled us to 
s equence the ent ire coding region of the gene , so that the 
mutations could be revealed at the sequence leve l . The 
d i sadvantage of us ing CHO/ aprt system to study teniposide 
mutagenes i s  is that the maj ority of the mutants recovered at 
thi s  locus may not be the types of mutations induced by 
tenipos ide at other genet ic loci , most of which are more 
s imi lar to hgprt mutants in s i z e . Only 1 0  % of the mutations 
recovered in th is study were large sca le a lterat ions . However , 
s e lect ive recovery of certa in types of mutations i s  a lmost 
i nevitable in any mutagenes i s  system . Th is study opened 
another window for invest igation of tenipos ide mutagenes i s .  
Characteristics o f  Teniposide- Induced Mutat ions at the aprt 
Locus 
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Compared t o  the spontaneous mutation spectrum , tenipos ide 
induced more sma l l  deletions ( 2 9 . 4  % vs . 2 1 . 4  % ) , insertions 
( 2 3 . 5  % vs . 7 . 1  %) and fewer base sUbst itut ions ( 3 6 . 7  % vs . 
6 4 . 3  % ) . Moreover , 1 0  % of the tenipos ide- induced mutations 
appear to be large deletions and rearrangements whi l e  no such 
mutants were formed spontaneously . 
Sma l l  deletions induced by teniposide are s imilar to 
spontaneous deletions in terms of s i z e  and the presence of  
short direct repeats at the mutation termini . A s igni f icant 
increase in the number of insertions was observed in 
tenipos ide- induced mutat ions . Eleven of the 16 insert ions are 
dup l i cations and eight of them are 4 base pairs or less . F ive 
med ium to large-s i z ed insertions ( 4 1 - 3 3 0  bp ) were found and 
two of them are dupl ications . Short direct repeats are a l s o  
involved in most of  the insertions . 
Increased frequency of sma l l  deletions and insert ions in 
the presence of tenipos ide rai sed the poss ibi l ity that 
topoi somerase II may play a role in the formation of 
spontaneous deletions and insert ions , s i nce the clastogenic 
e ffect of tenipos ide i s  mediated by thi s  enzyme . Furthermore , 
the invo lvement of short direct repeats in both spontaneous 
and teniposide- induced sma l l  deletions and insertions tempted 
the thoughts that these repeated sequences might serve as some 
sort of  recognition s igna l for topo isomerase II bind ing to 
DNA . The maj ority of the spontaneous deletions and insertions 
that f e l l  into exons 2 ,  3 ,  4 and 5 do not associate with 
strong in vi tro cleavage s ites ( Figure 1 8 ) , which is in sharp 
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contrast t o  the drug- induced sma l l  deletions and insertions . 
However , this result st i l l  does not address the question o f  
whether the increased frequenc ies of  sma l l  deletion and 
insertions in the presence of tenipos ide is due to the 
enhancement of a preexi st ing mechanism for the formation of 
spontaneous deletions and insert ions , s ince the drug­
stimulated cleavage s ites may not be the same as s ites of 
topo isomerase-mediated c leavage in the untreated cel l s . 
Despite the unfavorable se lection against large deletions 
and rearrangements in CHO / aprt system , several mutants of  thi s  
type were recovered . S ince n o  such mutants were found in the 
spontaneous group , it is almost certa in that this type of 
mutat ion represents solely tenipos ide- induced DNA alterat ions . 
It would be more va luable if these mutants were ana lyz ed at 
the sequence leve l ,  s ince they probably reflect more closely 
the type of DNA damage and repa ir events which occur in c e l l s  
f o l l owing tenipos ide exposure . 
A predominance of G · C  � A · T  trans itions in spontaneous 
base sUbstitut ions was observed previously ( Phear et a 1 . ,  
1 9 8 9 ; de Jong et a l . , 1 9 8 8 )  and i s  also true in thi s  study . 
But thi s  type of base sUbst itut ion is much less preva l ent 
among teniposide- induced substitut ions . Instead , transvers ions 
occurred more frequent ly than trans itions . Thi s  may be due to 
the observed shift of frequency from G · C  � A · T  to G · C  � C · G  
and G · C  � T · A in the presence of tenipos ide . The preval ence of 
G · C  � A · T  trans it ions in spontaneous base sUbstitution was 
suggested to ref lect cytos ine deaminat ion ( de Jong et a l . , 
1 1 9  
1 9 8 8 ) . Enhancement of other types of base changes may be 
responsible for the shift of  the base sUbst itut ion spectrum . 
The distribution of tenipos ide- induced base sUbstitut ions 
i s  not not iceably d i fferent from that of  spontaneous base 
sUbstitutions . In fact , several of  the drug- induced 
sUbstitutions f e l l  at the same base pairs that were found in 
the spontaneous group . Tenipos ide- induced base sUbstitut ions 
did not appear to occur preferent i a l ly at s ites of  drug­
st imulated cleavage , and the mechanism of the ir format ion i s  
unknown . One possibil ity is drug-induced interference with 
repair of endogenous DNA base les ions . Most of the drug­
induced base sUbstitut ions targeted amino acids that are also 
targeted by spontaneous base sUbst itutions . However , several 
amino acids alterat ions that have never been reported before 
were found in both the spontaneous and the tenipos ide- induced 
group . 
Correspondence Between in vi tro Cleavage s ites and the 
Ten ipos ide-Induced Mutant Seguences 
By means of the two analyses shown in Tables 11 and 1 2 , 
the relationship between teniposide- induced mutations and the 
in vi tro cleavage s ites was expressed in a quant itat ive way 
and a s igni f icant correspondence was indicated . The 
association between strong cleavage s ites and the mutant 
sequences is more than 2 times greater than the random 
background and 17 t imes greater than the non-random background 
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( Table 1 1 ) . It suggests that the strong s ites are more l ikely 
to be the initial s ites of DNA damage , whereas the weak s ites 
may only play a minor role , i f  any , in the format ion of  the 
mutat ions . Twenty-three of the 2 8  tenipos ide- i nduced 
deletion / dupl icat ion mutations were found to assoc iate with 
strong in vi tro cleavage s ite ( s )  ( Table 1 2 ) and most of  these 
s ites are 4 base staggered double strand cleavage s ites . 
These data imply that the in vi tro c leavage s ites may , to 
some extent , represent the s ites of initial DNA les ions 
occurring in the ce l l s  following teniposide exposure , and a 
s igni f i cant portion of tenipos ide-induced sma l l  deletions and 
dup l i cations may have resulted from these DNA double strand 
breaks that were mediated by topo isomerase I I . A previous 
study which was done by Ripley et a l  ( 1 9 8 8 )  is  clearly in 
f avor of  this presumpt ion . In the ir work , frameshift hotspot 
s ites for acridine- induced mutations in bacter iophage T4 were 
found to correspond to two very strong in vi tro topo isomerase 
I I  cleavage s ites . This observation not only imp l i cated the 
acridine- induced , topo isomerase II mediated DNA cleavages as 
being respons ible for the acridine-induced frameshift 
mutat ions , but also demonstrated that the topoisomerase I I  
mediated i n  vi vo cleavages were able t o  b e  reproduced i n  a 
c e l l  free system with the same sequence spec i f i c ity . 
However , recent observations have indicated that the 
pattern of  topo isomerase II mediated DNA cleavage in naked DNA 
is substant i a l ly different from that shown to occur in the 
drosoph i l a  KC cells ( Udvardy and Sched l , 1 9 9 1 ) . Spec i f i ca l ly ,  
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c leavage s ites within nuc leosome core particles are suppressed 
whi l e  those in the internucleosome l i nker or in other 
nuc leosome free areas are enhanced . As a result , the observed 
relationship between tenipos ide- induced mutations and in vi tro 
c leavage s ites may only part i a l ly ref l ect what had happened in 
the c e l l s . 
Mode l s  for poss ible Cel lular Mutationa l Events 
The topo isomerase II mediated DNA double strand break has 
been character i z ed as two s ingle strand cleavages on oppos ite 
strands , separated by four base pairs , result ing in a 5 , _  
overhang (Mul ler et a l . ,  1 9 8 8 ) . In thi s  study , we observed 3 1  
strong in vi tro c leavage s ites in exons 2 ,  3 ,  4 and 5 ,  among 
which 22 s ites are positioned in such a way that double strand 
c leavage can occur . All of the 11 putat ive double c leavage 
s ites are associated with at least one teniposide- induced 
deletion/dup l icat ion mutat ion . Two of these s ites are each 
associated with four deletions and dupl ications . Thi s  unusua l 
observation strongly suggests that topo isomerase I I  mediated 
DNA strand breaks , espec i a l ly the double strand breaks , were 
the initial les ions which resulted in tenipos ide- induced 
mutations . This presumption enables us to try to address the 
question as how these mutat ions might be produced , wh ich could 
lead to a better understand ing of the mechan i sms of  DNA double 
strand break repair . 
The format ion of the mutations presumably occurred dur ing 
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certain genetic activities such as repl ication , transcription 
and chromosoma l segregat ion when topoisomerase II is  requ ired . 
The mutations are probably e ither the outcomes of incorrect 
DNA strand break repa ir or rep l i cation errors due to the 
interference with norma l DNA synthes i s  by the drug-stab i l i z ed 
DNA-topo isomerase I I  complexes . By examining the pos itions of  
the double cleavage s ites in the mutant sequences ,  no  
con s istent pattern was found which could explain the formation 
of  all the mutat ions . However , severa l mode ls are presented 
below ,  each of which describes possible events occurring in 
the c e l l s  fol lowing tenipos ide exposure wh ich could have 
resulted in observed mutat ions . 
( 1 )  Ripley ' s  Model : 
Ripley et al ( 1 9 8 8 )  proposed that a topo isomerase I I  
mediated DNA strand break would expose a free 3 '  hydroxyl end 
which could be acted on by two dif ferent kind of enzymes : a 
3 ' -exonuclease could tr im off a few nuc leotides and cova lent 
rej o ining of the ends cou ld form a deletion ; DNA polymerase 
could fill in the s ingle stranded 5 '  overhang and subsequent 
rej o ining of the ends cou ld form a dup l i cation . Five mutants 
in thi s  study (mutants 3 4 t , 9 1t ,  2 8 t ,  2 2 t ,  8 3 t )  could be 
exp l a i ned by this model ( F igure 1 9 ) . 
( 2 )  Nonhomo logous Recombination Model : 
Nonhomologous recombination has been described by many 
i nvestigators as an commonly seen mechan ism of doubl e  strand 
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F igure 1 9 . Ripley ' s  Mode l . 1 .  In vi tro tenipos ide­
st imulated , topo isomerase I I -mediated double cleavage s ite . 2 .  
A strand displacement reaction is cata lyzed by DNA polymerase . 
3 .  A dup l i cation is formed by rej oin ing of the ends . 
1 .  
2.  
3.  
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break repa ir i n  mamma l ian cel l s . When l i near DNA molecules 
with d i fferent ends were introduced into monkey cel l s , the 
ends were j o ined with l imited sequence mod i f i cations despite 
the fact that l ittl e  or no homo logy was present ( Roth and 
W i lson , 1 9 8 6 ) . Figure 20 i l lustrates that one or both ends of 
a double strand break could be processed by exonucleases unt i l  
some sequence homo logy is exposed . The cohes ive ends are then 
rej o ined and the gaps are f i l led .  The observed short d irect 
repeats which appear at nearly all of the deletion termini may 
be the outcome of thi s  sequence homo logy searching process .  
But whether or not thi s  short sequence homo logy i s  required 
for thi s  type of double strand break repa ir or i f  there is 
some other mechanism invo lved is  not clear at th is  po int . 
Twelve mutants ( 7 3 t ,  4 9t ,  7 1t ,  5 2 t , 1 0 1t ,  2 9t ,  5 6t ,  7 6t ,  5 5 t , 
9 6 t ,  3 t  and 2 2 t )  could be expla ined by th i s  model . Among them , 
mutant 2 2 t could a l s o  be expla ined by Ripley ' s  mode l . Mutant 
2 4 t  is located in the region where no lower strand c leavage 
s ites could be recogn i z ed . The fact that one strong c leavage 
s ite is present at the upper strand makes it pos s ible that 
mutant 2 4 t  could also be expla ined by th is model . The most 
attractive feature of the nonhomo logous recombinat ion mode l i s  
that it can account for both the predominance of  strong 
c leavage s ites within the deleted sequences ,  and the l ack of 
any con s istent posit ion ing of these c leavage s ites with 
respect to the delet ion termin i .  
( 3 )  Rep l ication Blockage and S l ippage Mode l : 
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F igure 2 0 .  Nonhomo logous Recombination Model . 1 .  In vi tro 
doubl e  c leavage si tes . 2 .  Both 3 I ends are acted on by 
exonucleases to expose short sequence homology ( under l ined 
sequence ) .  3 .  The ends are rej o ined to form a deletion . 
Nonhomologous Recombinat ion Model  
1 .  
2 .  
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Four of the 1 1  dupl ications ( 1t ,  3 7 t ,  2 3 t ,  3 9t )  a r e  not 
a ssociated with in vi tro cleavage s ites in the way that the 
formation of these mutants could be expla ined by Ripley ' s  
mode l . These dup l ications are located at various d istances 
from double c leavage s ites . Short d irect repeats are a l s o  
present a t  the termini of these dup l ications and o n e  o f  the 
repeated sequences is dupl icated . These mutat ions could be DNA 
rep l i cation errors . Figure 2 1  i l lustrates that when the DNA 
repl ication complex is progress ing along the leading strand 
and reaches the drug-stab i l i z ed topo isomerase I I  intermediate , 
the s imp le phys ical blockage may cause DNA po lymerase to s l ip 
back . The short sequence of a direct repeat in the newly 
synthes i z ed region could base pair with comp l imentary sequence 
at the opposite strand whi l e  the rest of it loops out . When 
the blockage is released , th is part of the sequence i s  
synthes i z ed aga in and a dup l ication i s  formed . 
( 4 )  Subunit Exchange Model : 
This mode l was f irst suggested by Ikeda ( 1 9 8 6 )  for a 
unique kind of DNA gyrase mediated recombinat ion . It was then 
genera l i z ed as i l lustrated in Figure 2 2 : DNA topo isomerase I I  
molecules bind t o  DNAs t o  form comp lexes , two such comp l exes 
associate with each other and lead to the exchange of  DNA 
strands through the exchange of topo isomerase II sUbunits . But 
none of the mutants found in this study could be exp l a ined by 
thi s  mode l . 
Among a l l  17 deletions and 1 1  dupl ications examined , 8 
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Figure 2 1 .  Blockage and S l ippage Model . 1 .  DNA rep l i cation 
Complex is  progress ing along the leading strand and reaches 
the drug stab i l i z ed topoi somerase II intermediate . 2 .  The 
physical blockage causes the repl ication comp lex to s l ip back 
and the newly synthes i z ed sequence loops out . 3 .  A dup l i cation 
i s  formed . 
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Figure 2 2 . Subunit Exchange Mode l . 1 .  DNA-topo isomerase I I  
comp l exes . 2 .  Two comp lexes assoc iate with each other and l ead 
to the exchange of DNA strands through the exchange of  
topo isomerase I I  sUbunits . 3 .  A deletion i s  formed . 
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mutants ( 3 8t , 5t , 11t , 15t , 1 3 t , 3 3 t ,  9 0t )  d o  not seem t o  f it 
any of the above mode l s . At this point , there is no good 
exp lanation as how these mutations might be formed . Mutants 
3 8 t ,  1 1t and 15t are s ingle base pair deletion or dup l i cations 
which may not be induced by tenipos ide , s ince these type s  of  
mutations could also be formed spontaneous ly . Mutant 33  has a 
comp l icated a lterat ion in which two deletions and one 
insertion were found near the base of  a putat ive stem loop 
structure at exon 5 .  The delet ions cover several d irect and 
inverted repeats which may play a role in the generat ion of 
the mutat ions . Mutant 9 0t carr ies multiple dup l ication/ 
insertion mutat ions ( Figure 2 3 )  wh ich start from the upstream 
splice j unction and extend into intron 4 .  Such a comp lex form 
of  mutation has never been reported before and may ref l ect a 
unique character istic of the repa ir of topo isomerase I I  
mediated double strand breaks . 
This study provided l ittle clue for the cause of DNA 
damages resulting in spontaneous deletions and dup l i cations . 
F ive of the spontaneous deletions and dupl ications are 
c lustered around a putat ive hair pin structure in exon 5 
( Figure 18 ) . Thi s  is consi stent with what was reported 
previously by other invest igators that spontaneous deletions 
occur more frequent ly around hair pin structures ( Phear et 
a l . , 1 9 8 9 ) . Although the cause of initial DNA damage might be 
dist inct , the presence of short direct repeats in both 
spontaneous and teniposide- induced mutations suggests a 
s imi lar mechanism of mutant format ion . 
GGCCACTGGAGGTAAGAGCCCACTCTGTAGCATAAAGAGGTTTCAAAGGGATAAGCCTA 
GGAGGT(AAGAGCCCACTCTGTAGb AAG(CATAAAGAG) 4 GT AAGAGCAT(AAAGAGGTITC1AAAGGGAT AAG 
Figure 23. Sequence analysis of mutant gOt. The dupl icated DNA seg me nts are i n  pare ntheses. The short 
horizontal l ines show the terminal repeats. 
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Impl ications for C l inical Cancer Chemotherapy 
Teniposide is current ly used in the c l inic as an 
e f f ecti ve cancer chemotherapeut ic agent . However , a unique 
type of acute monocyt ic leukemia has been identif ied in recent 
years among long term cancer survivors who were treated with 
epipodophyllotoxins or certa in other topo isomerase I I  
i nhibitors . Thi s  type of secondary leukemia are often found to 
have trans locations invo lving chromosome 1 1q2 3 . It i s  l ikely 
that certa in spec i f i c  genet ic events were induced by the drug , 
which could trigger the process of transformat ion . However , 
most of the genet ic events in secondary cancers are not known 
at the present time . 
In this study , we ana lyz ed the tenipos ide- induced 
mutat ions at the DNA sequence leve l in a mamma lian mutagene s i s  
model system . The observed evidence suggests that the maj ority 
of tenipos ide- induced mutat ions are probably resulted from 
c leavable complex , the DNA les ion which presumably cause ce l l  
death . Therefore n o  immediate hope of separat ing the two 
e f f ects in one drug has emerged from th i s  study . 
However , the work does show that teniposide can induce 
mutations other than large delet ions . As the genetic events in 
secondary cancers are di scovered , such as wh ich type of 
mutation is important in the deve lopment of secondary cancers , 
our results compr ise a useful data base for compar ison to 
determine whether tenipos ide was directly invo lved . 
The exact relation between cl eavable comp lex formation 
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and either cell death o r  mutagenes i s  i s  sti l l  not certa i n ,  nor 
is it known why some cleavable comp lexes produce actua l 
chromosome breaks in the ce l l ,  or whether this breakage i s  
important in cell  death . Thus , it i s  possible that c leavable 
comp l exes with certain drugs may be less l ikely to produce 
frank DNA double strand breaks than those with other drugs . 
Whether this would increase or decrease mutagenes i s  relative 
to c e l l  k i l l  cannot be determined unt i l  mechanisms of  both 
c e l l  death and mutagenes i s  by these drugs are e lucidated in 
more deta i l . The present study represents a sma l l  but 
essential step toward that goa l . 
Future Studies 
The present study has provided suggestive evidence for 
certain mode ls to explain the mutagenic events occurr ing in 
the cells . But the evidence is st i l l  far from proving the 
va l id ity of these models . Additiona l stud ies could be done in 
the future to try to address the rema in ing quest ions . ( 1 )  
S ince the interca lat ive topo isomerase I I  inhibitor m-AMSA has 
d i f ferent and stronger sequence spec i f ic ity , this drug could 
be used to induce aprt- mutants and st imulate the in vi tro DNA 
c leavage to see if mutat ions also assoc iate with strong s ites . 
( 2 )  Some of the mode ls proposed above requ ire DNA rep l ication 
and some of them do not . It wou ld be interesting to obta in 
mutants deve loped from stationary phase cells to see which 
types of  mutants require DNA rep l i cation . For examp l e , the 
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nonhomologous recombination model wou ld not requ ire 
rep l i cation . ( 3 )  The large deletions and insertions could be 
sequenced in the future to determine whether they are 
qua l itatively s imilar to other mutants but s imply involve 
l arger segments of  DNA . ( 4 )  To ver i fy that i f  we are looking 
at double strand break repair events , a def ined DNA substrate 
with a s ingle topoisomerase I I - l inked break at a spec i f i c  s ite 
could be made to determine how these breaks are processed in 
trans fect ion assays or by nuc lear extracts . Th is study could 
eventual ly lead to the elucidat ion of the deta i l s  of double 
strand break repa ir mechanisms inc luding iso lation of  enzymes 
invo lved . 
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